PL208713B1 - Związek stanowiący pochodną tiofenu, kompozycja farmaceutyczna zawierająca taki związek i jego zastosowanie - Google Patents
Związek stanowiący pochodną tiofenu, kompozycja farmaceutyczna zawierająca taki związek i jego zastosowanieInfo
- Publication number
- PL208713B1 PL208713B1 PL367080A PL36708002A PL208713B1 PL 208713 B1 PL208713 B1 PL 208713B1 PL 367080 A PL367080 A PL 367080A PL 36708002 A PL36708002 A PL 36708002A PL 208713 B1 PL208713 B1 PL 208713B1
- Authority
- PL
- Poland
- Prior art keywords
- thiophene
- phenyl
- compound
- carboxylic
- amino
- Prior art date
Links
- 150000003577 thiophenes Chemical class 0.000 title claims description 3
- 239000003443 antiviral agent Substances 0.000 title description 6
- 206010054261 Flavivirus infection Diseases 0.000 title 1
- -1 cyano, azido, amidino Chemical group 0.000 claims description 1123
- 239000002253 acid Substances 0.000 claims description 669
- 150000001875 compounds Chemical class 0.000 claims description 616
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 110
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 103
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 98
- 125000001544 thienyl group Chemical group 0.000 claims description 74
- 125000004076 pyridyl group Chemical group 0.000 claims description 72
- 125000002541 furyl group Chemical group 0.000 claims description 62
- 125000000335 thiazolyl group Chemical group 0.000 claims description 62
- 125000000623 heterocyclic group Chemical group 0.000 claims description 61
- 125000004193 piperazinyl group Chemical group 0.000 claims description 61
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 59
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 59
- 125000003725 azepanyl group Chemical group 0.000 claims description 58
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 58
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 58
- 125000003386 piperidinyl group Chemical group 0.000 claims description 58
- 229910052736 halogen Inorganic materials 0.000 claims description 56
- 150000002367 halogens Chemical class 0.000 claims description 56
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 54
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 52
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 claims description 52
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 52
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims description 48
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 48
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 47
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 47
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 47
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 47
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims description 46
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 46
- 125000004655 dihydropyridinyl group Chemical group N1(CC=CC=C1)* 0.000 claims description 45
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 45
- 125000003320 C2-C6 alkenyloxy group Chemical group 0.000 claims description 44
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 40
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 37
- 125000001424 substituent group Chemical group 0.000 claims description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims description 36
- 241000711549 Hepacivirus C Species 0.000 claims description 33
- 125000001041 indolyl group Chemical group 0.000 claims description 33
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 26
- 125000000532 dioxanyl group Chemical group 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 21
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 20
- 230000003612 virological effect Effects 0.000 claims description 19
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 18
- 108060004795 Methyltransferase Proteins 0.000 claims description 16
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 16
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 15
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 11
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 10
- 125000001624 naphthyl group Chemical group 0.000 claims description 10
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 9
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 claims description 9
- 241000710831 Flavivirus Species 0.000 claims description 9
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 claims description 8
- 125000006491 4-t-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 8
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 8
- 229910052738 indium Inorganic materials 0.000 claims description 8
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 8
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 8
- 125000006507 2,4-difluorobenzyl group Chemical group [H]C1=C(F)C([H])=C(F)C(=C1[H])C([H])([H])* 0.000 claims description 7
- 125000003852 3-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])* 0.000 claims description 7
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 7
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims description 6
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Chemical group C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 6
- 150000001409 amidines Chemical class 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 6
- 125000004494 ethyl ester group Chemical group 0.000 claims description 6
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 6
- 125000005936 piperidyl group Chemical group 0.000 claims description 6
- 125000005247 tetrazinyl group Chemical group N1=NN=NC(=C1)* 0.000 claims description 6
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 5
- ORGXXKHNNJNAPB-UHFFFAOYSA-N 3-[(4-chlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)C1=CC=C(Cl)C=C1 ORGXXKHNNJNAPB-UHFFFAOYSA-N 0.000 claims description 5
- 208000036142 Viral infection Diseases 0.000 claims description 5
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 230000009385 viral infection Effects 0.000 claims description 5
- 229910052727 yttrium Inorganic materials 0.000 claims description 5
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 claims description 4
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 claims description 4
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- NYYKDALOYDQKPA-UHFFFAOYSA-N 3-(n-(2,4-dichlorobenzoyl)anilino)-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C=1C=CC=CC=1)C(=O)C1=CC=C(Cl)C=C1Cl NYYKDALOYDQKPA-UHFFFAOYSA-N 0.000 claims description 4
- GZNQIZXDGFRFOT-UHFFFAOYSA-N 3-[(2-chloro-4-cyanophenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC(=CC=2)C#N)Cl)=C(C(O)=O)S1 GZNQIZXDGFRFOT-UHFFFAOYSA-N 0.000 claims description 4
- CORJOVCCNWIHJE-UHFFFAOYSA-N 3-[(2-chlorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1Cl CORJOVCCNWIHJE-UHFFFAOYSA-N 0.000 claims description 4
- BACMTCNFHNDMIM-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 BACMTCNFHNDMIM-UHFFFAOYSA-N 0.000 claims description 4
- CDEZPEKCNFPDPF-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-(4-chlorophenyl)thiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC(Cl)=CC=2)C(O)=O)=C1C CDEZPEKCNFPDPF-UHFFFAOYSA-N 0.000 claims description 4
- NXUAAIVUPKHHNC-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(C)C=2)C)=C(C(O)=O)S1 NXUAAIVUPKHHNC-UHFFFAOYSA-N 0.000 claims description 4
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 4
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 4
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 4
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 claims description 4
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 229910052705 radium Inorganic materials 0.000 claims description 4
- 229910052701 rubidium Inorganic materials 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 claims description 4
- 150000003536 tetrazoles Chemical class 0.000 claims description 4
- 125000003944 tolyl group Chemical group 0.000 claims description 4
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 claims description 3
- NSTBKJQXCZFJQD-UHFFFAOYSA-N 3-(benzenesulfonamido)-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1 NSTBKJQXCZFJQD-UHFFFAOYSA-N 0.000 claims description 3
- WRAGVVOJOWAXNX-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(1-phenylethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=CC=CC=1C(C)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl WRAGVVOJOWAXNX-UHFFFAOYSA-N 0.000 claims description 3
- JOAHXELYGZYEKF-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(1-piperidin-4-ylethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(C)C1CCNCC1 JOAHXELYGZYEKF-UHFFFAOYSA-N 0.000 claims description 3
- ZDEYYXQNNKHDQW-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-piperidin-4-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CCNCC1 ZDEYYXQNNKHDQW-UHFFFAOYSA-N 0.000 claims description 3
- HRSASDAMXLSXNA-UHFFFAOYSA-N 3-[(4-bromo-2-methylphenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC(Br)=CC=2)C)=C(C(O)=O)S1 HRSASDAMXLSXNA-UHFFFAOYSA-N 0.000 claims description 3
- BMWYCRYHUCPJQB-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonyl-[(3-iodophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)N(CC=2C=C(I)C=CC=2)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1C BMWYCRYHUCPJQB-UHFFFAOYSA-N 0.000 claims description 3
- CEYROHUHAOEQKA-UHFFFAOYSA-N 3-[(4-methylphenyl)methyl-(2-methylpropanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)C(C)C)CC1=CC=C(C)C=C1 CEYROHUHAOEQKA-UHFFFAOYSA-N 0.000 claims description 3
- NJYCOGNPAOHBPY-UHFFFAOYSA-N 3-[(4-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 NJYCOGNPAOHBPY-UHFFFAOYSA-N 0.000 claims description 3
- HCWAVDVJWSEPGB-UHFFFAOYSA-N 3-[(4-nitrophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 HCWAVDVJWSEPGB-UHFFFAOYSA-N 0.000 claims description 3
- INSHPAQZHIADPY-UHFFFAOYSA-N 3-[[4-(2-chlorophenyl)piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)N(CC1)CCN1C1=CC=CC=C1Cl INSHPAQZHIADPY-UHFFFAOYSA-N 0.000 claims description 3
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 claims description 3
- RCLMWXCWXOTDLV-UHFFFAOYSA-N 5-(2-methoxyphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound COC1=CC=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC=CC=2)C)=C(C(O)=O)S1 RCLMWXCWXOTDLV-UHFFFAOYSA-N 0.000 claims description 3
- HTZLXJVFYOWLRB-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(Cl)C=CC=2)=C1 HTZLXJVFYOWLRB-UHFFFAOYSA-N 0.000 claims description 3
- XAHFETWNXTYUNL-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(Cl)C=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 XAHFETWNXTYUNL-UHFFFAOYSA-N 0.000 claims description 3
- ZFZJJUVWTSSAKV-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC(C=2SC(=C(NS(=O)(=O)C=3C(=CC=CC=3)C)C=2)C(O)=O)=C1 ZFZJJUVWTSSAKV-UHFFFAOYSA-N 0.000 claims description 3
- ILSVCOAMNUHJHS-UHFFFAOYSA-N 5-(4-cyanophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(=CC=2)C#N)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 ILSVCOAMNUHJHS-UHFFFAOYSA-N 0.000 claims description 3
- UJFMCKASZXENEG-UHFFFAOYSA-N 5-[4-(2-methylpropyl)phenyl]-3-[(2,3,4-trifluorophenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=C(F)C(F)=CC=2)F)=C(C(O)=O)S1 UJFMCKASZXENEG-UHFFFAOYSA-N 0.000 claims description 3
- YVZWGWVMODRXBK-UHFFFAOYSA-N 5-phenyl-3-[[2-(trifluoromethyl)phenyl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1C(F)(F)F YVZWGWVMODRXBK-UHFFFAOYSA-N 0.000 claims description 3
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 claims description 3
- 241001024304 Mino Species 0.000 claims description 3
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 claims description 3
- 229940126179 compound 72 Drugs 0.000 claims description 3
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 claims description 3
- 125000004475 heteroaralkyl group Chemical group 0.000 claims description 3
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 229920002554 vinyl polymer Polymers 0.000 claims description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 claims description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 claims description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims description 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 claims description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 claims description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 claims description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 claims description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 claims description 2
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 claims description 2
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 claims description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 claims description 2
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 claims description 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 claims description 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 claims description 2
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims description 2
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 2
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 claims description 2
- QTMAZYGAVHCKKX-UHFFFAOYSA-N 2-[(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)methoxy]propane-1,3-diol Chemical compound NC1=NC=NC2=C1C(Br)=CN2COC(CO)CO QTMAZYGAVHCKKX-UHFFFAOYSA-N 0.000 claims description 2
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 claims description 2
- HPDPVPUXPBZBOJ-UHFFFAOYSA-N 2-[chloro(difluoro)methoxy]-1,1,1-trifluoroethane Chemical compound FC(F)(F)COC(F)(F)Cl HPDPVPUXPBZBOJ-UHFFFAOYSA-N 0.000 claims description 2
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 claims description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 claims description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 2
- BVRDQVRQVGRNHG-UHFFFAOYSA-N 2-morpholin-4-ylpyrimido[2,1-a]isoquinolin-4-one Chemical compound N1=C2C3=CC=CC=C3C=CN2C(=O)C=C1N1CCOCC1 BVRDQVRQVGRNHG-UHFFFAOYSA-N 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims description 2
- KIGWKGOHKYYIAI-UHFFFAOYSA-N 3-(benzenesulfonamido)-5-(4-fluorophenyl)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC(F)=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1 KIGWKGOHKYYIAI-UHFFFAOYSA-N 0.000 claims description 2
- QZRSIMHJKPJNGI-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(3-methylpiperidin-4-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1CNCCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl QZRSIMHJKPJNGI-UHFFFAOYSA-N 0.000 claims description 2
- DXONPQJRKFZCKN-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(Cl)C=C1Cl DXONPQJRKFZCKN-UHFFFAOYSA-N 0.000 claims description 2
- RDIVPHJUVZQCLI-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-piperidin-3-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CCCNC1 RDIVPHJUVZQCLI-UHFFFAOYSA-N 0.000 claims description 2
- ZPZUZQRCMZBWFD-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-(1,3-thiazol-2-yl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2SC=CN=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl ZPZUZQRCMZBWFD-UHFFFAOYSA-N 0.000 claims description 2
- BVAOOKPQBDTCBU-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-pyrrolidin-3-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CCNC1 BVAOOKPQBDTCBU-UHFFFAOYSA-N 0.000 claims description 2
- RNJSJPFDMYEHPI-UHFFFAOYSA-N 3-[(2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=C(C)C(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1 RNJSJPFDMYEHPI-UHFFFAOYSA-N 0.000 claims description 2
- GFVFXPOLIYLJIJ-UHFFFAOYSA-N 3-[(2,6-dichlorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=C(Cl)C=CC=C1Cl GFVFXPOLIYLJIJ-UHFFFAOYSA-N 0.000 claims description 2
- CLFYRSHVENOGNI-UHFFFAOYSA-N 3-[(2-chlorophenyl)methyl-(cyclohexanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CCCCC1)CC1=CC=CC=C1Cl CLFYRSHVENOGNI-UHFFFAOYSA-N 0.000 claims description 2
- JHRUSQWNTIPXBE-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(OC(F)(F)F)=CC=2)=C1 JHRUSQWNTIPXBE-UHFFFAOYSA-N 0.000 claims description 2
- CXYGYPHEHLODBL-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-pyridin-3-ylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=NC=CC=2)=C1 CXYGYPHEHLODBL-UHFFFAOYSA-N 0.000 claims description 2
- LPMCPDOXHWVFPI-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-pyridin-4-ylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CN=CC=2)=C1 LPMCPDOXHWVFPI-UHFFFAOYSA-N 0.000 claims description 2
- IZHPXYFZBISFBL-UHFFFAOYSA-N 3-[(2-nitrophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1[N+]([O-])=O IZHPXYFZBISFBL-UHFFFAOYSA-N 0.000 claims description 2
- KKLZXWYEIQIINC-UHFFFAOYSA-N 3-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=NOC(C)=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 KKLZXWYEIQIINC-UHFFFAOYSA-N 0.000 claims description 2
- WUTORWIFOQXIBF-UHFFFAOYSA-N 3-[(3-chlorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC(Cl)=C1 WUTORWIFOQXIBF-UHFFFAOYSA-N 0.000 claims description 2
- IFYDSAQQCBQQLB-UHFFFAOYSA-N 3-[(3-methoxyphenyl)sulfonylamino]-4-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound COC1=CC=CC(S(=O)(=O)NC2=C(SC=C2C=2C=CC(CC(C)C)=CC=2)C(O)=O)=C1 IFYDSAQQCBQQLB-UHFFFAOYSA-N 0.000 claims description 2
- FADMNFYVMHVZHQ-UHFFFAOYSA-N 3-[(3-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1 FADMNFYVMHVZHQ-UHFFFAOYSA-N 0.000 claims description 2
- HNLKVRCRMCFRQW-UHFFFAOYSA-N 3-[(4-bromo-2-fluorophenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC(Br)=CC=2)F)=C(C(O)=O)S1 HNLKVRCRMCFRQW-UHFFFAOYSA-N 0.000 claims description 2
- JSJQZUGOENHZHG-UHFFFAOYSA-N 3-[(4-bromophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(Br)C=C1 JSJQZUGOENHZHG-UHFFFAOYSA-N 0.000 claims description 2
- ZZQWZFBHGGEYGU-UHFFFAOYSA-N 3-[(4-chloro-2,5-difluorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC(F)=C(Cl)C=C1F ZZQWZFBHGGEYGU-UHFFFAOYSA-N 0.000 claims description 2
- BAKXZKJTPJRHML-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-(4-fluorophenyl)thiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC(F)=CC=2)C(O)=O)=C1C BAKXZKJTPJRHML-UHFFFAOYSA-N 0.000 claims description 2
- CPQXFRZMYBYGEH-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl-(3-methylbutanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC(C)C)CC1=CC=C(Cl)C=C1 CPQXFRZMYBYGEH-UHFFFAOYSA-N 0.000 claims description 2
- XOTWANLGDMFVLK-UHFFFAOYSA-N 3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=C(C)C(OC)=CC(C)=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 XOTWANLGDMFVLK-UHFFFAOYSA-N 0.000 claims description 2
- NIZZTCVKFVRQFM-UHFFFAOYSA-N 3-[(4-methylbenzoyl)-prop-2-enylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)N(CC=C)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 NIZZTCVKFVRQFM-UHFFFAOYSA-N 0.000 claims description 2
- UOPWSCWEIVISCZ-UHFFFAOYSA-N 3-[(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 UOPWSCWEIVISCZ-UHFFFAOYSA-N 0.000 claims description 2
- HOHBYDOEENIDFB-UHFFFAOYSA-N 3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]-5-[4-(trifluoromethyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(=CC=2)C(F)(F)F)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1 HOHBYDOEENIDFB-UHFFFAOYSA-N 0.000 claims description 2
- GMMRESYELJNHFC-UHFFFAOYSA-N 3-[(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decane-8-carbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)N(CC1)CCC1(C(NC1)=O)N1C1=CC=CC=C1 GMMRESYELJNHFC-UHFFFAOYSA-N 0.000 claims description 2
- CCNMTSFOHGMZLG-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)methyl-(cyclohexanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CN(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1CCCCC1 CCNMTSFOHGMZLG-UHFFFAOYSA-N 0.000 claims description 2
- YTXIZXJHVWFYLQ-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)methyl-propanoylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC)CC1=CC=C(C(C)(C)C)C=C1 YTXIZXJHVWFYLQ-UHFFFAOYSA-N 0.000 claims description 2
- MWOAQWRUUGBPQC-UHFFFAOYSA-N 3-[(5-chloro-1,3-dimethylpyrazol-4-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=NN(C)C(Cl)=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 MWOAQWRUUGBPQC-UHFFFAOYSA-N 0.000 claims description 2
- SELUYVFFCIPMKQ-UHFFFAOYSA-N 3-[2-hydroxyethyl-(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)N(CCO)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 SELUYVFFCIPMKQ-UHFFFAOYSA-N 0.000 claims description 2
- QASOMRTWDNRYGT-UHFFFAOYSA-N 3-[[2,3-difluoro-4-(trifluoromethyl)benzoyl]-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C(F)(F)F)C(F)=C1F QASOMRTWDNRYGT-UHFFFAOYSA-N 0.000 claims description 2
- NKWOBYOHBPWASF-UHFFFAOYSA-N 3-[[2,5-bis(2,2,2-trifluoroethoxy)phenyl]sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC=C(OCC(F)(F)F)C=2)OCC(F)(F)F)=C(C(O)=O)S1 NKWOBYOHBPWASF-UHFFFAOYSA-N 0.000 claims description 2
- HNWQICAGMFFVLZ-UHFFFAOYSA-N 3-[butanoyl-[(3-chlorophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CCC)CC1=CC=CC(Cl)=C1 HNWQICAGMFFVLZ-UHFFFAOYSA-N 0.000 claims description 2
- FQQRXTXEEOVEHM-UHFFFAOYSA-N 3-[cyclobutanecarbonyl-[(3-methoxyphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound COC1=CC=CC(CN(C(=O)C2CCC2)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1 FQQRXTXEEOVEHM-UHFFFAOYSA-N 0.000 claims description 2
- ZXSGAJYIHJBVCN-UHFFFAOYSA-N 3-[cyclobutanecarbonyl-[(4-methylphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1CN(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1CCC1 ZXSGAJYIHJBVCN-UHFFFAOYSA-N 0.000 claims description 2
- ZAPVRTUHFZSULH-UHFFFAOYSA-N 3-[cyclopropanecarbonyl-[(3-methylphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC(CN(C(=O)C2CC2)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1 ZAPVRTUHFZSULH-UHFFFAOYSA-N 0.000 claims description 2
- HOEWJRXSNBUUSG-UHFFFAOYSA-N 3-[methyl(3-methylbutanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C)C(=O)CC(C)C)C=C1C1=CC=CC=C1 HOEWJRXSNBUUSG-UHFFFAOYSA-N 0.000 claims description 2
- GMDOMWOAZGYHCG-UHFFFAOYSA-N 3-[methyl-(2-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=CC=C1C GMDOMWOAZGYHCG-UHFFFAOYSA-N 0.000 claims description 2
- GVCLNACSYKYUHP-UHFFFAOYSA-N 4-amino-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]pyrimidine-5-carbothioamide Chemical compound C1=NC(N)=C2C(C(=S)N)=CN(COCCO)C2=N1 GVCLNACSYKYUHP-UHFFFAOYSA-N 0.000 claims description 2
- AYMYUKDAIRNOIE-UHFFFAOYSA-N 5-(2-carboxyphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C(=CC=CC=2)C(O)=O)=C1 AYMYUKDAIRNOIE-UHFFFAOYSA-N 0.000 claims description 2
- XFDIHLNCKGHJIF-UHFFFAOYSA-N 5-(3,4-dichlorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(Cl)C(Cl)=CC=2)=C1 XFDIHLNCKGHJIF-UHFFFAOYSA-N 0.000 claims description 2
- NFXZBSGFEIDKTI-UHFFFAOYSA-N 5-(3,4-difluorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(F)C(F)=CC=2)=C1 NFXZBSGFEIDKTI-UHFFFAOYSA-N 0.000 claims description 2
- XYFZUGCUFUXXGU-UHFFFAOYSA-N 5-(4-acetylphenyl)-3-[(4-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(C(=O)C)=CC=C1C1=CC(NS(=O)(=O)C=2C=CC(C)=CC=2)=C(C(O)=O)S1 XYFZUGCUFUXXGU-UHFFFAOYSA-N 0.000 claims description 2
- IVEHHMJVVPJWPX-UHFFFAOYSA-N 5-(4-chlorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(Cl)=CC=2)=C1 IVEHHMJVVPJWPX-UHFFFAOYSA-N 0.000 claims description 2
- LBYJOUYORZEBLZ-UHFFFAOYSA-N 5-(4-fluorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(F)=CC=2)=C1 LBYJOUYORZEBLZ-UHFFFAOYSA-N 0.000 claims description 2
- NGEHNLSCGFIISI-UHFFFAOYSA-N 5-(5-chloropyridin-2-yl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2N=CC(Cl)=CC=2)=C1 NGEHNLSCGFIISI-UHFFFAOYSA-N 0.000 claims description 2
- QIPDHDRHVPDMEH-UHFFFAOYSA-N 5-[3,5-bis(trifluoromethyl)phenyl]-3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)C(O)=O)=C1C QIPDHDRHVPDMEH-UHFFFAOYSA-N 0.000 claims description 2
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 claims description 2
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 claims description 2
- RVACAOYDDPOVDD-UHFFFAOYSA-N 5-phenyl-3-(pyridin-2-ylsulfonylamino)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=N1 RVACAOYDDPOVDD-UHFFFAOYSA-N 0.000 claims description 2
- HTXTXXLYPFNSFB-UHFFFAOYSA-N 5-phenyl-3-[[4-(trifluoromethyl)phenyl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 HTXTXXLYPFNSFB-UHFFFAOYSA-N 0.000 claims description 2
- KGXUVJQRPZEPAG-UHFFFAOYSA-N 5-phenyl-3-[[4-[3-(trifluoromethyl)phenyl]piperazine-1-carbonyl]amino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)N(CC1)CCN1C1=CC=CC(C(F)(F)F)=C1 KGXUVJQRPZEPAG-UHFFFAOYSA-N 0.000 claims description 2
- LVUCWLUPSLTAQY-UHFFFAOYSA-N 5-tert-butyl-3-[(4-chlorophenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound S1C(C(C)(C)C)=CC(NS(=O)(=O)C=2C=CC(Cl)=CC=2)=C1C(O)=O LVUCWLUPSLTAQY-UHFFFAOYSA-N 0.000 claims description 2
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 claims description 2
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 claims description 2
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 claims description 2
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 claims description 2
- XVZXOLOFWKSDSR-UHFFFAOYSA-N Cc1cc(C)c([C]=O)c(C)c1 Chemical group Cc1cc(C)c([C]=O)c(C)c1 XVZXOLOFWKSDSR-UHFFFAOYSA-N 0.000 claims description 2
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 claims description 2
- 229940127007 Compound 39 Drugs 0.000 claims description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 claims description 2
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 claims description 2
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 claims description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 claims description 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 claims description 2
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 claims description 2
- KNOCDBZPOREEQE-UHFFFAOYSA-N [2-[(2-carboxy-5-phenylthiophen-3-yl)-(2,4-dichlorobenzoyl)amino]cyclohexyl]azanium;chloride Chemical compound [Cl-].[NH3+]C1CCCCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl KNOCDBZPOREEQE-UHFFFAOYSA-N 0.000 claims description 2
- OGUWJLNIWQMXQN-UHFFFAOYSA-N [Cl-].[NH+](CC)(CC)C1=NC=C(CN(C(=O)C2=C(Cl)C=C(Cl)C=C2)C2=C(SC(=C2)C2=CC=CC=C2)C(O)=O)S1 Chemical compound [Cl-].[NH+](CC)(CC)C1=NC=C(CN(C(=O)C2=C(Cl)C=C(Cl)C=C2)C2=C(SC(=C2)C2=CC=CC=C2)C(O)=O)S1 OGUWJLNIWQMXQN-UHFFFAOYSA-N 0.000 claims description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims description 2
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 claims description 2
- 239000004305 biphenyl Chemical group 0.000 claims description 2
- 235000010290 biphenyl Nutrition 0.000 claims description 2
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 claims description 2
- 229940125904 compound 1 Drugs 0.000 claims description 2
- 229940125797 compound 12 Drugs 0.000 claims description 2
- 229940126543 compound 14 Drugs 0.000 claims description 2
- 229940125758 compound 15 Drugs 0.000 claims description 2
- 229940125782 compound 2 Drugs 0.000 claims description 2
- 229940125810 compound 20 Drugs 0.000 claims description 2
- 229940126086 compound 21 Drugs 0.000 claims description 2
- 229940126208 compound 22 Drugs 0.000 claims description 2
- 229940125833 compound 23 Drugs 0.000 claims description 2
- 229940125961 compound 24 Drugs 0.000 claims description 2
- 229940125851 compound 27 Drugs 0.000 claims description 2
- 229940127204 compound 29 Drugs 0.000 claims description 2
- 229940126214 compound 3 Drugs 0.000 claims description 2
- 229940125877 compound 31 Drugs 0.000 claims description 2
- 229940125878 compound 36 Drugs 0.000 claims description 2
- 229940125807 compound 37 Drugs 0.000 claims description 2
- 229940127573 compound 38 Drugs 0.000 claims description 2
- 229940126540 compound 41 Drugs 0.000 claims description 2
- 229940125936 compound 42 Drugs 0.000 claims description 2
- 229940127271 compound 49 Drugs 0.000 claims description 2
- 229940125898 compound 5 Drugs 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 claims description 2
- 125000004188 dichlorophenyl group Chemical group 0.000 claims description 2
- DFBKLUNHFCTMDC-GKRDHZSOSA-N endrin Chemical compound C([C@@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@@H]2[C@H]2[C@@H]1O2 DFBKLUNHFCTMDC-GKRDHZSOSA-N 0.000 claims description 2
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 claims description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims description 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 claims description 2
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 claims description 2
- 125000005394 methallyl group Chemical group 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- IHCHOVVAJBADAH-UHFFFAOYSA-N n-[2-hydroxy-4-(1h-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2h-chromene-3-carboxamide Chemical compound C1C2=CC(OC)=CC=C2OCC1C(=O)NC(C(=C1)O)=CC=C1C=1C=NNC=1 IHCHOVVAJBADAH-UHFFFAOYSA-N 0.000 claims description 2
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 claims description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 10
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 claims 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 claims 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 claims 1
- VUEGYUOUAAVYAS-JGGQBBKZSA-N (6ar,9s,10ar)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline Chemical compound C1=CC([C@H]2C[C@@H](CN(C)[C@@H]2C2)NS(=O)(=O)N(C)C)=C3C2=CNC3=C1 VUEGYUOUAAVYAS-JGGQBBKZSA-N 0.000 claims 1
- MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 claims 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 claims 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims 1
- PKJBWOWQJHHAHG-UHFFFAOYSA-N 1-bromo-4-phenylbenzene Chemical group C1=CC(Br)=CC=C1C1=CC=CC=C1 PKJBWOWQJHHAHG-UHFFFAOYSA-N 0.000 claims 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 claims 1
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 claims 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 claims 1
- 125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 claims 1
- SKMKJBYBPYBDMN-RYUDHWBXSA-N 3-(difluoromethoxy)-5-[2-(3,3-difluoropyrrolidin-1-yl)-6-[(1s,4s)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrimidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC(F)F)C(N)=NC=C1C1=CC(N2[C@H]3C[C@H](OC3)C2)=NC(N2CC(F)(F)CC2)=N1 SKMKJBYBPYBDMN-RYUDHWBXSA-N 0.000 claims 1
- DWQUAPIEHOIEQQ-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(1,3-dihydroxypropan-2-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(CO)CO)C(=O)C1=CC=C(Cl)C=C1Cl DWQUAPIEHOIEQQ-UHFFFAOYSA-N 0.000 claims 1
- XKOSCJAUHRVOPI-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-(3-methylphenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C)C=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl XKOSCJAUHRVOPI-UHFFFAOYSA-N 0.000 claims 1
- LUUIBUPKEZXBPP-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-piperidin-4-ylthiophene-2-carboxylic acid Chemical compound C1=C(C2CCNCC2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl LUUIBUPKEZXBPP-UHFFFAOYSA-N 0.000 claims 1
- RNBAMECJOQJHHH-UHFFFAOYSA-N 3-[(2,4-dichlorophenyl)methylcarbamoyl]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1C(=O)NCC1=CC=C(Cl)C=C1Cl RNBAMECJOQJHHH-UHFFFAOYSA-N 0.000 claims 1
- HQFLWMORIZZXHF-UHFFFAOYSA-N 3-[(2,4-difluorophenyl)sulfonylamino]-5-(4-fluorophenyl)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC(F)=CC=2)=CC=1NS(=O)(=O)C1=CC=C(F)C=C1F HQFLWMORIZZXHF-UHFFFAOYSA-N 0.000 claims 1
- DSUMSXCFDTVNNF-UHFFFAOYSA-N 3-[(2,4-dimethylbenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1C DSUMSXCFDTVNNF-UHFFFAOYSA-N 0.000 claims 1
- YIKVXZJXLVDZIZ-UHFFFAOYSA-N 3-[(2,4-dimethylphenyl)sulfonylamino]-5-(4-methylsulfonylphenyl)thiophene-2-carboxylic acid Chemical compound CC1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)S(C)(=O)=O)=C1 YIKVXZJXLVDZIZ-UHFFFAOYSA-N 0.000 claims 1
- RTIMLZXIJBOCGN-UHFFFAOYSA-N 3-[(2,5-dichlorothiophen-3-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C=1C=C(Cl)SC=1Cl RTIMLZXIJBOCGN-UHFFFAOYSA-N 0.000 claims 1
- UOJWDCADFJVARK-UHFFFAOYSA-N 3-[(2,5-dimethylphenyl)sulfonylamino]-5-(4-methylphenyl)thiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC=C(C)C=2)C)=C(C(O)=O)S1 UOJWDCADFJVARK-UHFFFAOYSA-N 0.000 claims 1
- VBCJTECWBMOYCO-UHFFFAOYSA-N 3-[(2-amino-4-chlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1N VBCJTECWBMOYCO-UHFFFAOYSA-N 0.000 claims 1
- BZAQHGRGVAQDPH-UHFFFAOYSA-N 3-[(2-bromo-4-chlorobenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(Cl)C=C1Br BZAQHGRGVAQDPH-UHFFFAOYSA-N 0.000 claims 1
- LKXVEMXRUUEKND-UHFFFAOYSA-N 3-[(2-chlorophenyl)methyl-(3-methylbutanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC(C)C)CC1=CC=CC=C1Cl LKXVEMXRUUEKND-UHFFFAOYSA-N 0.000 claims 1
- NOWYSEONYZIDTQ-UHFFFAOYSA-N 3-[(2-cyanophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1C#N NOWYSEONYZIDTQ-UHFFFAOYSA-N 0.000 claims 1
- JDGZCKCRTKXERS-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(1,3-thiazol-2-yl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2SC=CN=2)=C1 JDGZCKCRTKXERS-UHFFFAOYSA-N 0.000 claims 1
- AJWSNQYTXSFOJK-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(1h-pyrazol-4-yl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C2=CNN=C2)=C1 AJWSNQYTXSFOJK-UHFFFAOYSA-N 0.000 claims 1
- CUHQPXASHRRGHN-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(3-nitrophenyl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(C=CC=2)[N+]([O-])=O)=C1 CUHQPXASHRRGHN-UHFFFAOYSA-N 0.000 claims 1
- DQDZZXKMHJAUQM-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(4-methylsulfonylphenyl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)S(C)(=O)=O)=C1 DQDZZXKMHJAUQM-UHFFFAOYSA-N 0.000 claims 1
- MYINBAPRIZCUIV-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-[2-(trifluoromethyl)phenyl]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C(=CC=CC=2)C(F)(F)F)=C1 MYINBAPRIZCUIV-UHFFFAOYSA-N 0.000 claims 1
- GVWAYNGOHLPMHK-UHFFFAOYSA-N 3-[(3,4-dichlorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(Cl)C(Cl)=C1 GVWAYNGOHLPMHK-UHFFFAOYSA-N 0.000 claims 1
- RCTWLZKPLKYHAX-UHFFFAOYSA-N 3-[(3,5-dichlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC(Cl)=CC(Cl)=C1 RCTWLZKPLKYHAX-UHFFFAOYSA-N 0.000 claims 1
- WGHSOYCMWSFBLO-UHFFFAOYSA-N 3-[(3-carboxycyclopentyl)-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1C(C(=O)O)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl WGHSOYCMWSFBLO-UHFFFAOYSA-N 0.000 claims 1
- SBOHZVRRASXAJB-UHFFFAOYSA-N 3-[(3-fluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 SBOHZVRRASXAJB-UHFFFAOYSA-N 0.000 claims 1
- ISEQPBXIOKXRGA-UHFFFAOYSA-N 3-[(4-chloro-2-fluorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1F ISEQPBXIOKXRGA-UHFFFAOYSA-N 0.000 claims 1
- MNHXBYXMXSZEQV-UHFFFAOYSA-N 3-[(4-chloro-2-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC(Cl)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 MNHXBYXMXSZEQV-UHFFFAOYSA-N 0.000 claims 1
- SEWFHWHJCAQHSE-UHFFFAOYSA-N 3-[(4-cyanobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C#N)C=C1 SEWFHWHJCAQHSE-UHFFFAOYSA-N 0.000 claims 1
- QCQDJUNCIHOIPV-UHFFFAOYSA-N 3-[(4-methyl-2-oxocyclohexanecarbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1=O QCQDJUNCIHOIPV-UHFFFAOYSA-N 0.000 claims 1
- RSOHIWMVEKWSLM-UHFFFAOYSA-N 3-[(4-methyl-2-phenylmethoxybenzoyl)-propan-2-ylamino]-5-[3-(trifluoromethyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1OCC1=CC=CC=C1 RSOHIWMVEKWSLM-UHFFFAOYSA-N 0.000 claims 1
- RBSSXGJWFHIKDF-UHFFFAOYSA-N 3-[(4-methylcyclohexanecarbonyl)-(oxan-4-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CC(C)CCC1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C1CCOCC1 RBSSXGJWFHIKDF-UHFFFAOYSA-N 0.000 claims 1
- HCFGJRXLTALWMP-UHFFFAOYSA-N 3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]-5-(3-methylphenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C)C=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1 HCFGJRXLTALWMP-UHFFFAOYSA-N 0.000 claims 1
- FARXTSDCCGZXMY-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)methyl-(cyclopropanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CN(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1CC1 FARXTSDCCGZXMY-UHFFFAOYSA-N 0.000 claims 1
- MBQNTNCRAIBFAQ-UHFFFAOYSA-N 3-[(5-bromo-6-chloropyridin-3-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CN=C(Cl)C(Br)=C1 MBQNTNCRAIBFAQ-UHFFFAOYSA-N 0.000 claims 1
- OZJMHDIIPLAFRX-UHFFFAOYSA-N 3-[1-benzofuran-2-carbonyl(methyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C2=CC=CC=C2OC=1C(=O)N(C)C(=C(S1)C(O)=O)C=C1C1=CC=CC=C1 OZJMHDIIPLAFRX-UHFFFAOYSA-N 0.000 claims 1
- DGBFOKFOXSKYJJ-UHFFFAOYSA-N 3-[[3-fluoro-4-(trifluoromethyl)benzoyl]-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C(F)(F)F)C(F)=C1 DGBFOKFOXSKYJJ-UHFFFAOYSA-N 0.000 claims 1
- CLEJRZBTEVUOSJ-UHFFFAOYSA-N 3-[[4-(6-methylpyridin-2-yl)piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC(N2CCN(CC2)C(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=N1 CLEJRZBTEVUOSJ-UHFFFAOYSA-N 0.000 claims 1
- QMQNVRIUSTUDGK-UHFFFAOYSA-N 3-[[4-[(4-chlorophenyl)methyl]piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)N(CC1)CCN1CC1=CC=C(Cl)C=C1 QMQNVRIUSTUDGK-UHFFFAOYSA-N 0.000 claims 1
- FZCWRHLIMUVHIE-UHFFFAOYSA-N 3-[butanoyl-[(2,4-difluorophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CCC)CC1=CC=C(F)C=C1F FZCWRHLIMUVHIE-UHFFFAOYSA-N 0.000 claims 1
- ZITWCPNLBDEOGY-UHFFFAOYSA-N 3-[methyl(4-methylpentanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C)C(=O)CCC(C)C)C=C1C1=CC=CC=C1 ZITWCPNLBDEOGY-UHFFFAOYSA-N 0.000 claims 1
- FBKFXDWSEYSFEY-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]-5-(3-nitrophenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)[N+]([O-])=O)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 FBKFXDWSEYSFEY-UHFFFAOYSA-N 0.000 claims 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 claims 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims 1
- GSDQYSSLIKJJOG-UHFFFAOYSA-N 4-chloro-2-(3-chloroanilino)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC1=CC=CC(Cl)=C1 GSDQYSSLIKJJOG-UHFFFAOYSA-N 0.000 claims 1
- LVOZLWLORQRMMV-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C(=CC(Cl)=CC=2)Cl)=C1 LVOZLWLORQRMMV-UHFFFAOYSA-N 0.000 claims 1
- BPCKZGKAPCMEJY-UHFFFAOYSA-N 5-(3,5-difluorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(F)C=C(F)C=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 BPCKZGKAPCMEJY-UHFFFAOYSA-N 0.000 claims 1
- MNPSEJXQPRBIEG-UHFFFAOYSA-N 5-(3-cyanophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(C=CC=2)C#N)=C1 MNPSEJXQPRBIEG-UHFFFAOYSA-N 0.000 claims 1
- MHNIOOCUIUVFKK-UHFFFAOYSA-N 5-(3-cyanophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)C#N)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 MHNIOOCUIUVFKK-UHFFFAOYSA-N 0.000 claims 1
- NNFNYSAHMPRLBE-UHFFFAOYSA-N 5-(3-ethoxycarbonylphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CCOC(=O)C1=CC=CC(C=2SC(=C(NS(=O)(=O)C=3C(=CC=CC=3)C)C=2)C(O)=O)=C1 NNFNYSAHMPRLBE-UHFFFAOYSA-N 0.000 claims 1
- UNXFGQASALRDKO-UHFFFAOYSA-N 5-(4-cyanophenyl)-3-[(4-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)C#N)=C1 UNXFGQASALRDKO-UHFFFAOYSA-N 0.000 claims 1
- ILTHQBFFEYQYOL-UHFFFAOYSA-N 5-(4-fluorophenyl)-3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(F)=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1 ILTHQBFFEYQYOL-UHFFFAOYSA-N 0.000 claims 1
- SQZHLRZSDCRCFU-UHFFFAOYSA-N 5-(furan-3-yl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C2=COC=C2)=C1 SQZHLRZSDCRCFU-UHFFFAOYSA-N 0.000 claims 1
- MPIOJUKUHWFITD-UHFFFAOYSA-N 5-phenyl-3-[(4-propan-2-ylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(C(C)C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 MPIOJUKUHWFITD-UHFFFAOYSA-N 0.000 claims 1
- CLGGAOUGQBNDGK-UHFFFAOYSA-N 5-phenyl-3-[[2-(trifluoromethoxy)phenyl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1OC(F)(F)F CLGGAOUGQBNDGK-UHFFFAOYSA-N 0.000 claims 1
- PUUUHPKNOUPVDT-UHFFFAOYSA-N 5-tert-butyl-3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C(C)(C)C)C(O)=O)=C1C PUUUHPKNOUPVDT-UHFFFAOYSA-N 0.000 claims 1
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 claims 1
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 claims 1
- SYZOFRXZMALRGI-JYJNAYRXSA-N CC1=C(NCC(F)(F)F)C(=O)N(C=C1)[C@@H](CC1CC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C#N Chemical compound CC1=C(NCC(F)(F)F)C(=O)N(C=C1)[C@@H](CC1CC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C#N SYZOFRXZMALRGI-JYJNAYRXSA-N 0.000 claims 1
- SCJNYBYSTCRPAO-LXBQGUBHSA-N CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 Chemical compound CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 SCJNYBYSTCRPAO-LXBQGUBHSA-N 0.000 claims 1
- YYPQKDBDLSDQQG-UHFFFAOYSA-N ClC1=CC=C(CCCC(=O)NC2=C(SC(=C2)C2=CC=CC=C2)C(=O)O)C=C1 Chemical compound ClC1=CC=C(CCCC(=O)NC2=C(SC(=C2)C2=CC=CC=C2)C(=O)O)C=C1 YYPQKDBDLSDQQG-UHFFFAOYSA-N 0.000 claims 1
- 229940126657 Compound 17 Drugs 0.000 claims 1
- CLCTZVRHDOAUGJ-UHFFFAOYSA-N N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[4-[[4-[2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxoisoindol-5-yl]piperazin-1-yl]methyl]piperidin-1-yl]pyridazine-3-carboxamide Chemical compound FC1=CC2=C(C=C1N1CCN(CC3CCN(CC3)C3=CC=C(N=N3)C(=O)NC3CCC(CC3)OC3=CC(Cl)=C(C=C3)C#N)CC1)C(=O)N(C1CCC(=O)NC1=O)C2=O CLCTZVRHDOAUGJ-UHFFFAOYSA-N 0.000 claims 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- DRBWRJPFNOBNIO-KOLCDFICSA-N [(2r)-1-[(2r)-2-(pyridine-4-carbonylamino)propanoyl]pyrrolidin-2-yl]boronic acid Chemical compound N([C@H](C)C(=O)N1[C@@H](CCC1)B(O)O)C(=O)C1=CC=NC=C1 DRBWRJPFNOBNIO-KOLCDFICSA-N 0.000 claims 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 claims 1
- YGPZYYDTPXVBRA-RTDBHSBRSA-N [(2r,3s,4r,5r,6s)-2-[[(2r,3r,4r,5s,6r)-3-[[(3r)-3-dodecanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxy-4-[(3r)-3-tetradecanoyloxytetradecanoyl]oxyoxan-2-yl]oxymethyl]-3,6-dihydroxy-5-[[(3r)-3-hydroxytetradecanoyl]amino]oxan-4-yl] (3r)-3-hydr Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](O)O1 YGPZYYDTPXVBRA-RTDBHSBRSA-N 0.000 claims 1
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 claims 1
- CWNKMHIETKEBCA-UHFFFAOYSA-N alpha-Ethylaminohexanophenone Chemical compound CCCCC(NCC)C(=O)C1=CC=CC=C1 CWNKMHIETKEBCA-UHFFFAOYSA-N 0.000 claims 1
- KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 claims 1
- 229940126142 compound 16 Drugs 0.000 claims 1
- DFBKLUNHFCTMDC-PICURKEMSA-N dieldrin Chemical compound C([C@H]1[C@H]2[C@@]3(Cl)C(Cl)=C([C@]([C@H]22)(Cl)C3(Cl)Cl)Cl)[C@H]2[C@@H]2[C@H]1O2 DFBKLUNHFCTMDC-PICURKEMSA-N 0.000 claims 1
- 150000003222 pyridines Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 251
- 239000000243 solution Substances 0.000 description 107
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 104
- 235000019439 ethyl acetate Nutrition 0.000 description 101
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 90
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 79
- 239000000460 chlorine Substances 0.000 description 73
- 238000005481 NMR spectroscopy Methods 0.000 description 69
- 239000011541 reaction mixture Substances 0.000 description 61
- 239000000203 mixture Substances 0.000 description 58
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 46
- 239000002904 solvent Substances 0.000 description 43
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 42
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 36
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 32
- 239000007787 solid Substances 0.000 description 32
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 28
- 229910052799 carbon Inorganic materials 0.000 description 28
- 239000010410 layer Substances 0.000 description 28
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 26
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
- 239000012044 organic layer Substances 0.000 description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 23
- 239000008346 aqueous phase Substances 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- 239000012267 brine Substances 0.000 description 19
- 239000003480 eluent Substances 0.000 description 19
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 19
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 18
- 229910052938 sodium sulfate Inorganic materials 0.000 description 18
- 235000011152 sodium sulphate Nutrition 0.000 description 18
- 239000007832 Na2SO4 Substances 0.000 description 17
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 17
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 17
- NUJXFKHOOMJUPO-UHFFFAOYSA-N methyl 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl NUJXFKHOOMJUPO-UHFFFAOYSA-N 0.000 description 17
- KWWGBNRBZMJKPA-UHFFFAOYSA-N 3-phenylthiophene-2-carboxylic acid Chemical compound S1C=CC(C=2C=CC=CC=2)=C1C(=O)O KWWGBNRBZMJKPA-UHFFFAOYSA-N 0.000 description 16
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 16
- 150000004702 methyl esters Chemical class 0.000 description 16
- 239000000741 silica gel Substances 0.000 description 16
- 229910002027 silica gel Inorganic materials 0.000 description 16
- 238000000746 purification Methods 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 14
- 239000004480 active ingredient Substances 0.000 description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 14
- 235000019341 magnesium sulphate Nutrition 0.000 description 14
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 13
- QESSCNMSOLRYBO-UHFFFAOYSA-N methyl 3-amino-5-phenylthiophene-2-carboxylate Chemical compound NC1=C(C(=O)OC)SC(C=2C=CC=CC=2)=C1 QESSCNMSOLRYBO-UHFFFAOYSA-N 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 12
- 230000008020 evaporation Effects 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 238000004440 column chromatography Methods 0.000 description 10
- 238000003818 flash chromatography Methods 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- QGMFBCDNJUZQBZ-UHFFFAOYSA-N 5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=CC=C1 QGMFBCDNJUZQBZ-UHFFFAOYSA-N 0.000 description 7
- 108091006112 ATPases Proteins 0.000 description 7
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 7
- 101710144111 Non-structural protein 3 Proteins 0.000 description 7
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 7
- 239000013058 crude material Substances 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- KCAQBNCKVFZVIT-UHFFFAOYSA-N methyl 3-[(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)C1=CC=C(Cl)C=C1Cl KCAQBNCKVFZVIT-UHFFFAOYSA-N 0.000 description 7
- 238000004237 preparative chromatography Methods 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- CEOCVKWBUWKBKA-UHFFFAOYSA-N 2,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1Cl CEOCVKWBUWKBKA-UHFFFAOYSA-N 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000000825 pharmaceutical preparation Substances 0.000 description 6
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 6
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 5
- IUADGPRSRYATIY-UHFFFAOYSA-N 2-[[3-[(4-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carbonyl]amino]acetic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(=O)NCC(O)=O)SC(C=2C=CC=CC=2)=C1 IUADGPRSRYATIY-UHFFFAOYSA-N 0.000 description 5
- UKNZREOUDLFUFF-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)(isopropyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl UKNZREOUDLFUFF-UHFFFAOYSA-N 0.000 description 5
- FBBNCVURFSVLFJ-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC=C1 FBBNCVURFSVLFJ-UHFFFAOYSA-N 0.000 description 5
- IBUFNMKTIXHEFK-UHFFFAOYSA-N 3-[benzoyl(methyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=CC=C1 IBUFNMKTIXHEFK-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000000969 carrier Substances 0.000 description 5
- 239000002270 dispersing agent Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- LBRXWPRTCUVBRS-UHFFFAOYSA-N 3-[(2,4-dichlorophenyl)-propan-2-ylcarbamoyl]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=C(Cl)C=C(Cl)C=1N(C(C)C)C(=O)C(=C(S1)C(O)=O)C=C1C1=CC=CC=C1 LBRXWPRTCUVBRS-UHFFFAOYSA-N 0.000 description 4
- CADPUALMFMAHDY-UHFFFAOYSA-N 3-amino-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N)C=C1C1=CC=CC=C1 CADPUALMFMAHDY-UHFFFAOYSA-N 0.000 description 4
- HEEHLQKXQGFGKV-UHFFFAOYSA-N 3-iodo-5-phenylthiophene-2-carboxylic acid Chemical compound IC1=C(C(=O)O)SC(C=2C=CC=CC=2)=C1 HEEHLQKXQGFGKV-UHFFFAOYSA-N 0.000 description 4
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 239000012139 lysis buffer Substances 0.000 description 4
- SPAKMVQVTSVXES-UHFFFAOYSA-N methanol;oxolane;hydrate Chemical compound O.OC.C1CCOC1 SPAKMVQVTSVXES-UHFFFAOYSA-N 0.000 description 4
- YAAGMAHPESSCLG-UHFFFAOYSA-N methyl 5-phenyl-3-(propan-2-ylamino)thiophene-2-carboxylate Chemical compound CC(C)NC1=C(C(=O)OC)SC(C=2C=CC=CC=2)=C1 YAAGMAHPESSCLG-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 238000012746 preparative thin layer chromatography Methods 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 125000006493 trifluoromethyl benzyl group Chemical group 0.000 description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- XWKLBOBCZKPNBY-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(piperidin-4-ylmethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)CC1CCNCC1 XWKLBOBCZKPNBY-UHFFFAOYSA-N 0.000 description 3
- GKOAPPFBYCPZJX-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-[[5-[3-(trifluoromethyl)phenyl]furan-2-yl]methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)CC(O1)=CC=C1C1=CC=CC(C(F)(F)F)=C1 GKOAPPFBYCPZJX-UHFFFAOYSA-N 0.000 description 3
- WHIBBUNFHUZCSG-UHFFFAOYSA-N 3-[(2,4-dichlorophenyl)methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCC1=CC=C(Cl)C=C1Cl WHIBBUNFHUZCSG-UHFFFAOYSA-N 0.000 description 3
- VVWRGFRAROIXHC-UHFFFAOYSA-N 3-[cyclopropyl-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CC1 VVWRGFRAROIXHC-UHFFFAOYSA-N 0.000 description 3
- 125000006482 3-iodobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(I)=C1[H])C([H])([H])* 0.000 description 3
- QOISRSRHPKALCR-UHFFFAOYSA-N 4-[(4-methylcyclohexanecarbonyl)amino]-5-(3-methylphenyl)-3-propan-2-ylthiophene-2-carboxylic acid Chemical compound C=1C=CC(C)=CC=1C=1SC(C(O)=O)=C(C(C)C)C=1NC(=O)C1CCC(C)CC1 QOISRSRHPKALCR-UHFFFAOYSA-N 0.000 description 3
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 3
- DMTLDMVIGRGWJZ-UHFFFAOYSA-N 5-(4-methylphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC=CC=2)C)=C(C(O)=O)S1 DMTLDMVIGRGWJZ-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 108700008776 hepatitis C virus NS-5 Proteins 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- WYFBSBFYTIHCMF-UHFFFAOYSA-N methyl 3-[bis[(2-methylphenyl)sulfonyl]amino]thiophene-2-carboxylate Chemical compound S1C=CC(N(S(=O)(=O)C=2C(=CC=CC=2)C)S(=O)(=O)C=2C(=CC=CC=2)C)=C1C(=O)OC WYFBSBFYTIHCMF-UHFFFAOYSA-N 0.000 description 3
- CDTRVQBWHPJPGM-UHFFFAOYSA-N methyl 3-iodo-5-phenylthiophene-2-carboxylate Chemical compound IC1=C(C(=O)OC)SC(C=2C=CC=CC=2)=C1 CDTRVQBWHPJPGM-UHFFFAOYSA-N 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000004533 oil dispersion Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- WYWIFABBXFUGLM-UHFFFAOYSA-N oxymetazoline Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C)=C1CC1=NCCN1 WYWIFABBXFUGLM-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 229960000329 ribavirin Drugs 0.000 description 3
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- LCPRDXDBYWFDSF-QYNIQEEDSA-N (1r,2s,4r)-2-hydroxy-4-methylcyclohexane-1-carboxylic acid Chemical compound C[C@@H]1CC[C@@H](C(O)=O)[C@@H](O)C1 LCPRDXDBYWFDSF-QYNIQEEDSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- DTNQAMXXKXILGM-UHFFFAOYSA-N 1-benzyl-6-phenylthieno[3,2-d][1,3]oxazine-2,4-dione Chemical compound O=C1OC(=O)C=2SC(C=3C=CC=CC=3)=CC=2N1CC1=CC=CC=C1 DTNQAMXXKXILGM-UHFFFAOYSA-N 0.000 description 2
- WUEPMEXUMQVEGN-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;2,2,2-trifluoro-n-[2-[2-[(2,2,2-trifluoroacetyl)amino]ethylamino]ethyl]acetamide Chemical compound OC(=O)C(F)(F)F.FC(F)(F)C(=O)NCCNCCNC(=O)C(F)(F)F WUEPMEXUMQVEGN-UHFFFAOYSA-N 0.000 description 2
- XWBIIJWERPBJRT-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonyl]-5-phenylthiophene-3-carboxylic acid Chemical compound OC(=O)C1=C(C(=O)OC(C)(C)C)SC(C=2C=CC=CC=2)=C1 XWBIIJWERPBJRT-UHFFFAOYSA-N 0.000 description 2
- NRZNTGUFHSJBTD-HKOYGPOVSA-N 2-[2-(2-methoxyethoxy)ethoxy]ethyl (e)-2-cyano-3-(6-piperidin-1-ylnaphthalen-2-yl)prop-2-enoate Chemical compound C1=CC2=CC(/C=C(C(=O)OCCOCCOCCOC)\C#N)=CC=C2C=C1N1CCCCC1 NRZNTGUFHSJBTD-HKOYGPOVSA-N 0.000 description 2
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 2
- 125000003541 2-chlorobenzoyl group Chemical group ClC1=C(C(=O)*)C=CC=C1 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- HGZLUPOHPDDIFN-UHFFFAOYSA-N 3-[(2,4-dichlorobenzenecarbothioyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=S)C1=CC=C(Cl)C=C1Cl HGZLUPOHPDDIFN-UHFFFAOYSA-N 0.000 description 2
- BWMKEDQQGCKQPB-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-[[2-(diethylamino)-1,3-thiazol-5-yl]methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(N(CC)CC)=NC=C1CN(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl BWMKEDQQGCKQPB-UHFFFAOYSA-N 0.000 description 2
- KGWQRYDTUDGPRS-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-(2-methylpropyl)thiophene-2-carboxylic acid Chemical compound S1C(CC(C)C)=CC(N(C(C)C)C(=O)C=2C(=CC(Cl)=CC=2)Cl)=C1C(O)=O KGWQRYDTUDGPRS-UHFFFAOYSA-N 0.000 description 2
- QPTYHBIZVDVMIN-UHFFFAOYSA-N 3-[(2-methylcyclohexanecarbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCCCC1C QPTYHBIZVDVMIN-UHFFFAOYSA-N 0.000 description 2
- HHSIYAYAFUPSSR-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(4-nitrophenyl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)[N+]([O-])=O)=C1 HHSIYAYAFUPSSR-UHFFFAOYSA-N 0.000 description 2
- ONUXSFFBVLQSPL-UHFFFAOYSA-N 3-[(3,4-difluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(F)C(F)=C1 ONUXSFFBVLQSPL-UHFFFAOYSA-N 0.000 description 2
- BUEYYUYOGBITTF-UHFFFAOYSA-N 3-[(3-bromophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC(Br)=C1 BUEYYUYOGBITTF-UHFFFAOYSA-N 0.000 description 2
- VNJBRVFTSYFMDY-UHFFFAOYSA-N 3-[(4,6-dichloro-1h-indole-2-carbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C2=C(Cl)C=C(Cl)C=C2NC=1C(=O)N(C(C)C)C(=C(S1)C(O)=O)C=C1C1=CC=CC=C1 VNJBRVFTSYFMDY-UHFFFAOYSA-N 0.000 description 2
- BHKHERHIEAOOFN-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1C BHKHERHIEAOOFN-UHFFFAOYSA-N 0.000 description 2
- LSCILVWEAWFOQC-UHFFFAOYSA-N 3-[(4-chlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1 LSCILVWEAWFOQC-UHFFFAOYSA-N 0.000 description 2
- USYDPWDCQLRHIY-UHFFFAOYSA-N 3-[(4-chlorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(Cl)C=C1 USYDPWDCQLRHIY-UHFFFAOYSA-N 0.000 description 2
- TUKLPSOBBMNHDR-UHFFFAOYSA-N 3-[[2-(chloromethyl)phenyl]sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1CCl TUKLPSOBBMNHDR-UHFFFAOYSA-N 0.000 description 2
- HNXVUHHNOWQZLR-UHFFFAOYSA-N 3-[acetyl(benzyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)C)CC1=CC=CC=C1 HNXVUHHNOWQZLR-UHFFFAOYSA-N 0.000 description 2
- FNBZXUWCFRORLO-UHFFFAOYSA-N 3-[acetyl-[(4-chlorophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)C)CC1=CC=C(Cl)C=C1 FNBZXUWCFRORLO-UHFFFAOYSA-N 0.000 description 2
- HJBVUFKHFIPDAV-UHFFFAOYSA-N 3-[benzyl(cyclopropanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CC1)CC1=CC=CC=C1 HJBVUFKHFIPDAV-UHFFFAOYSA-N 0.000 description 2
- BKKLZCFDGSSMIM-UHFFFAOYSA-N 3-[butanoyl-[(3-methylphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CCC)CC1=CC=CC(C)=C1 BKKLZCFDGSSMIM-UHFFFAOYSA-N 0.000 description 2
- JPLAPBKPSYSENB-UHFFFAOYSA-N 3-[cyclobutanecarbonyl-[(2-methylphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1CN(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1CCC1 JPLAPBKPSYSENB-UHFFFAOYSA-N 0.000 description 2
- IDKCAQJAGNTIHF-UHFFFAOYSA-N 3-[ethyl-(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC)C(=O)C1=CC=C(C)C=C1 IDKCAQJAGNTIHF-UHFFFAOYSA-N 0.000 description 2
- QCXVHVJSYWWRHY-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]-5-(3-methylphenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C)C=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 QCXVHVJSYWWRHY-UHFFFAOYSA-N 0.000 description 2
- WLJQGIHPQWAMSH-UHFFFAOYSA-N 3-[tert-butyl-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)(C)C)C(=O)C1=CC=C(Cl)C=C1Cl WLJQGIHPQWAMSH-UHFFFAOYSA-N 0.000 description 2
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 description 2
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 2
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- QTDXSEZXAPHVBI-UHFFFAOYSA-N 4-methylcyclohexane-1-carboxylic acid Chemical compound CC1CCC(C(O)=O)CC1 QTDXSEZXAPHVBI-UHFFFAOYSA-N 0.000 description 2
- DQIRFGSUYVNJGJ-UHFFFAOYSA-N 5-(1-benzothiophen-2-yl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2SC3=CC=CC=C3C=2)=C1 DQIRFGSUYVNJGJ-UHFFFAOYSA-N 0.000 description 2
- BAJWBSHYIOAKDO-UHFFFAOYSA-N 5-(2-fluorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C(=CC=CC=2)F)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 BAJWBSHYIOAKDO-UHFFFAOYSA-N 0.000 description 2
- FXOJQJBROSJRHW-UHFFFAOYSA-N 5-(3-chloro-4-fluorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(Cl)C(F)=CC=2)=C1 FXOJQJBROSJRHW-UHFFFAOYSA-N 0.000 description 2
- FCJOOCHSXUKBHV-UHFFFAOYSA-N 5-phenyl-3-(thiophen-2-ylsulfonylamino)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CS1 FCJOOCHSXUKBHV-UHFFFAOYSA-N 0.000 description 2
- JXGBCNVRXSKFTH-UHFFFAOYSA-N 5-tert-butyl-3-[(2,4-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C(C)(C)C)=C1 JXGBCNVRXSKFTH-UHFFFAOYSA-N 0.000 description 2
- MVEOHWRUBFWKJY-UHFFFAOYSA-N 7-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=CC(S(O)(=O)=O)=CC2=CC(O)=CC=C21 MVEOHWRUBFWKJY-UHFFFAOYSA-N 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 102000006992 Interferon-alpha Human genes 0.000 description 2
- 108010047761 Interferon-alpha Proteins 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 101710144128 Non-structural protein 2 Proteins 0.000 description 2
- 101710199667 Nuclear export protein Proteins 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001263 acyl chlorides Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000000068 chlorophenyl group Chemical group 0.000 description 2
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 2
- UBKHHFOBCZFFKL-UHFFFAOYSA-N cyclopenta[c]pyran Chemical compound C1=COC=C2C=CC=C21 UBKHHFOBCZFFKL-UHFFFAOYSA-N 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- RJGHQTVXGKYATR-UHFFFAOYSA-L dibutyl(dichloro)stannane Chemical compound CCCC[Sn](Cl)(Cl)CCCC RJGHQTVXGKYATR-UHFFFAOYSA-L 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- DPGZDBYEZILPOW-UHFFFAOYSA-N ethyl 3-methylcyclopent-3-ene-1-carboxylate Chemical compound CCOC(=O)C1CC=C(C)C1 DPGZDBYEZILPOW-UHFFFAOYSA-N 0.000 description 2
- SGRJGEKHJKAPLX-UHFFFAOYSA-N ethyl 4-methyl-2-prop-2-enylpent-4-enoate Chemical compound CCOC(=O)C(CC=C)CC(C)=C SGRJGEKHJKAPLX-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- FMKOJHQHASLBPH-UHFFFAOYSA-N isopropyl iodide Chemical compound CC(C)I FMKOJHQHASLBPH-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- PBKFWYSVDHUAAO-PRJMDXOYSA-N methyl (1r,2s,4r)-2-hydroxy-4-methylcyclohexane-1-carboxylate Chemical compound COC(=O)[C@@H]1CC[C@@H](C)C[C@@H]1O PBKFWYSVDHUAAO-PRJMDXOYSA-N 0.000 description 2
- IXWKURXBULWANS-UHFFFAOYSA-N methyl 3-(cyclopropylamino)-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC1CC1 IXWKURXBULWANS-UHFFFAOYSA-N 0.000 description 2
- CRZIZFRKZXZOTF-UHFFFAOYSA-N methyl 3-(n-(2,4-dichlorobenzoyl)anilino)-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C=1C=CC=CC=1)C(=O)C1=CC=C(Cl)C=C1Cl CRZIZFRKZXZOTF-UHFFFAOYSA-N 0.000 description 2
- XJNXHBMFZYDDGE-UHFFFAOYSA-N methyl 3-(tert-butylamino)-5-phenylthiophene-2-carboxylate Chemical compound CC(C)(C)NC1=C(C(=O)OC)SC(C=2C=CC=CC=2)=C1 XJNXHBMFZYDDGE-UHFFFAOYSA-N 0.000 description 2
- HNDNBPMQCVYEHY-UHFFFAOYSA-N methyl 3-[(2,4-dichlorophenyl)methylamino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCC1=CC=C(Cl)C=C1Cl HNDNBPMQCVYEHY-UHFFFAOYSA-N 0.000 description 2
- OKZMNYOVTVEOLD-UHFFFAOYSA-N methyl 3-[(4-chloro-2,5-dimethylphenyl)sulfonyl-[(3-iodophenyl)methyl]amino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(S(=O)(=O)C=1C(=CC(Cl)=C(C)C=1)C)CC1=CC=CC(I)=C1 OKZMNYOVTVEOLD-UHFFFAOYSA-N 0.000 description 2
- IOLIGIWPLLWKFK-UHFFFAOYSA-N methyl 3-[(4-chlorobenzoyl)amino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)C1=CC=C(Cl)C=C1 IOLIGIWPLLWKFK-UHFFFAOYSA-N 0.000 description 2
- DVWGDXMSZBVHDA-UHFFFAOYSA-N methyl 3-[[3-(1-benzofuran-2-yl)phenyl]methyl-(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(CC=1C=C(C=CC=1)C=1OC2=CC=CC=C2C=1)S(=O)(=O)C1=CC(C)=C(Cl)C=C1C DVWGDXMSZBVHDA-UHFFFAOYSA-N 0.000 description 2
- FHPBFACJVOLOSC-UHFFFAOYSA-N methyl 3-[cyclopropyl-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CC1 FHPBFACJVOLOSC-UHFFFAOYSA-N 0.000 description 2
- NVWHTWXQIACPNP-UHFFFAOYSA-N methyl 3-[tert-butyl-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(C)(C)C)C(=O)C1=CC=C(Cl)C=C1Cl NVWHTWXQIACPNP-UHFFFAOYSA-N 0.000 description 2
- UOBCTMFUXPNJFD-UHFFFAOYSA-N methyl 3-anilino-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC1=CC=CC=C1 UOBCTMFUXPNJFD-UHFFFAOYSA-N 0.000 description 2
- VVHIYNKJAAFNEK-UHFFFAOYSA-N methyl 5-phenyl-3-[[5-[3-(trifluoromethyl)phenyl]furan-2-yl]methylamino]thiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCC(O1)=CC=C1C1=CC=CC(C(F)(F)F)=C1 VVHIYNKJAAFNEK-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- PARWUHTVGZSQPD-UHFFFAOYSA-N phenylsilane Chemical compound [SiH3]C1=CC=CC=C1 PARWUHTVGZSQPD-UHFFFAOYSA-N 0.000 description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- NFXAGUHNMCMRKV-UHFFFAOYSA-M sodium;3-(benzylamino)-5-phenylthiophene-2-carboxylate Chemical compound [Na+].[O-]C(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCC1=CC=CC=C1 NFXAGUHNMCMRKV-UHFFFAOYSA-M 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 241000701447 unidentified baculovirus Species 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- NRTQCUWVVQFZIC-VDAHYXPESA-N (1r,2s,4r)-2-acetyloxy-4-methylcyclohexane-1-carboxylic acid Chemical compound C[C@@H]1CC[C@@H](C(O)=O)[C@@H](OC(C)=O)C1 NRTQCUWVVQFZIC-VDAHYXPESA-N 0.000 description 1
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- BIWQNIMLAISTBV-UHFFFAOYSA-N (4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1 BIWQNIMLAISTBV-UHFFFAOYSA-N 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- YQYGGOPUTPQHAY-KIQLFZLRSA-N (4S)-4-[[(2S)-2-[[(2S)-2-[2-[6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-5-amino-1-[[(4S,7R)-7-[[(2S)-1-[(2S)-6-amino-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-4-carboxy-2-hydrazinylbutanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-2-methyl-5,6-dioxooctan-4-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-4-amino-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-6-oxohexyl]hydrazinyl]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-5-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-1-hydroxy-3-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC[C@@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1ccccc1)NC(=O)C(CCCCNN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)[C@H](C)O)C(C)C)[C@H](C)O YQYGGOPUTPQHAY-KIQLFZLRSA-N 0.000 description 1
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 1
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- ILROLYQPRYHHFG-UHFFFAOYSA-N 1-$l^{1}-oxidanylprop-2-en-1-one Chemical group [O]C(=O)C=C ILROLYQPRYHHFG-UHFFFAOYSA-N 0.000 description 1
- BACZSVQZBSCWIG-UHFFFAOYSA-N 1-(bromomethyl)-3-iodobenzene Chemical compound BrCC1=CC=CC(I)=C1 BACZSVQZBSCWIG-UHFFFAOYSA-N 0.000 description 1
- OSIGJGFTADMDOB-UHFFFAOYSA-N 1-Methoxy-3-methylbenzene Chemical compound COC1=CC=CC(C)=C1 OSIGJGFTADMDOB-UHFFFAOYSA-N 0.000 description 1
- WJIFKOVZNJTSGO-UHFFFAOYSA-N 1-bromo-3-methylbenzene Chemical compound CC1=CC=CC(Br)=C1 WJIFKOVZNJTSGO-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- OSOUNOBYRMOXQQ-UHFFFAOYSA-N 1-chloro-3-methylbenzene Chemical compound CC1=CC=CC(Cl)=C1 OSOUNOBYRMOXQQ-UHFFFAOYSA-N 0.000 description 1
- IRSVDHPYXFLLDS-UHFFFAOYSA-N 2,4-dichloro-1-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1Cl IRSVDHPYXFLLDS-UHFFFAOYSA-N 0.000 description 1
- VMHXZIVQBSZLOL-UHFFFAOYSA-N 2,4-dichloro-n-propan-2-ylaniline Chemical compound CC(C)NC1=CC=C(Cl)C=C1Cl VMHXZIVQBSZLOL-UHFFFAOYSA-N 0.000 description 1
- LXUNZSDDXMPKLP-UHFFFAOYSA-N 2-Methylbenzenethiol Chemical compound CC1=CC=CC=C1S LXUNZSDDXMPKLP-UHFFFAOYSA-N 0.000 description 1
- APDYPEOKIUKUQV-UHFFFAOYSA-N 2-[1-(2-oxo-2-piperidin-1-ylethyl)indol-4-yl]oxy-6-(trifluoromethyl)pyridine-4-carbonitrile Chemical compound O=C(CN1C=CC2=C(C=CC=C12)OC=1C=C(C#N)C=C(N=1)C(F)(F)F)N1CCCCC1 APDYPEOKIUKUQV-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- YOWQWFMSQCOSBA-UHFFFAOYSA-N 2-methoxypropene Chemical compound COC(C)=C YOWQWFMSQCOSBA-UHFFFAOYSA-N 0.000 description 1
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 1
- FICAQKBMCKEFDI-UHFFFAOYSA-N 3,5-dimethyl-1,2-oxazole Chemical compound CC=1C=C(C)ON=1 FICAQKBMCKEFDI-UHFFFAOYSA-N 0.000 description 1
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 1
- WXYZLSHVMIALBJ-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(1-methylpiperidin-4-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CN(C)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl WXYZLSHVMIALBJ-UHFFFAOYSA-N 0.000 description 1
- QGKSHLYEEQZABJ-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(1-phenylmethoxypropan-2-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(C)COCC1=CC=CC=C1 QGKSHLYEEQZABJ-UHFFFAOYSA-N 0.000 description 1
- ONSIURJVALFIOM-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(2,2-dimethyl-1,3-dioxan-5-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1OC(C)(C)OCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl ONSIURJVALFIOM-UHFFFAOYSA-N 0.000 description 1
- SDHGIQHXUTWDNP-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(2-methoxycyclohexyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound COC1CCCCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl SDHGIQHXUTWDNP-UHFFFAOYSA-N 0.000 description 1
- LJMOEDINVVMTSY-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(2-methylpropyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC(C)C)C(=O)C1=CC=C(Cl)C=C1Cl LJMOEDINVVMTSY-UHFFFAOYSA-N 0.000 description 1
- PRJDUWACXUZMSN-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(3-methyl-1-phenylmethoxycarbonylpiperidin-4-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1CN(C(=O)OCC=2C=CC=CC=2)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl PRJDUWACXUZMSN-UHFFFAOYSA-N 0.000 description 1
- JWOJDHKUUGWJDA-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(3-methylbut-2-enyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC=C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl JWOJDHKUUGWJDA-UHFFFAOYSA-N 0.000 description 1
- OQOYFCILKXRELY-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-[1-[(2-methylpropan-2-yl)oxycarbonylamino]propan-2-yl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(CNC(=O)OC(C)(C)C)C)C(=O)C1=CC=C(Cl)C=C1Cl OQOYFCILKXRELY-UHFFFAOYSA-N 0.000 description 1
- CYZFMUXXYDBFCJ-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-piperidin-4-ylamino]-5-phenylthiophene-2-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CCNCC1 CYZFMUXXYDBFCJ-UHFFFAOYSA-N 0.000 description 1
- AIKPRWLFYWLCKW-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-(1h-indol-5-yl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C3C=CNC3=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl AIKPRWLFYWLCKW-UHFFFAOYSA-N 0.000 description 1
- KXCBVTIGHBAEDE-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-(4-methylsulfinylphenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(=CC=2)S(C)=O)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl KXCBVTIGHBAEDE-UHFFFAOYSA-N 0.000 description 1
- PGXNCMGLSWROGR-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-[3-(trifluoromethyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl PGXNCMGLSWROGR-UHFFFAOYSA-N 0.000 description 1
- IFAFYQRLKPZZCK-UHFFFAOYSA-N 3-[(2,4-difluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(F)C=C1F IFAFYQRLKPZZCK-UHFFFAOYSA-N 0.000 description 1
- ZHZVLXKMEIGIBV-UHFFFAOYSA-N 3-[(2,4-dimethylbenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1C ZHZVLXKMEIGIBV-UHFFFAOYSA-N 0.000 description 1
- PLVCZHMJJSVBSU-UHFFFAOYSA-N 3-[(2,4-dimethylphenyl)sulfonyl-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=C(C)C=C(C)C=1S(=O)(=O)N(C(C)C)C(=C(S1)C(O)=O)C=C1C1=CC=CC=C1 PLVCZHMJJSVBSU-UHFFFAOYSA-N 0.000 description 1
- ZMRBEGJRTUKELM-UHFFFAOYSA-N 3-[(2,5-dimethylphenyl)sulfonylamino]-5-(4-fluorophenyl)thiophene-2-carboxylic acid Chemical compound CC1=CC=C(C)C(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC(F)=CC=2)C(O)=O)=C1 ZMRBEGJRTUKELM-UHFFFAOYSA-N 0.000 description 1
- ZGRPGYLLZKRKOR-UHFFFAOYSA-N 3-[(2,6-dichloropyridin-4-yl)carbamoylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)NC1=CC(Cl)=NC(Cl)=C1 ZGRPGYLLZKRKOR-UHFFFAOYSA-N 0.000 description 1
- VRACSOUSWLPIBZ-UHFFFAOYSA-N 3-[(2,6-dichloropyridine-3-carbonyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(Cl)N=C1Cl VRACSOUSWLPIBZ-UHFFFAOYSA-N 0.000 description 1
- YELLGDSBMHNWOL-UHFFFAOYSA-N 3-[(2,6-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC(C)=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 YELLGDSBMHNWOL-UHFFFAOYSA-N 0.000 description 1
- MTVCHEWHEXHTEZ-UHFFFAOYSA-N 3-[(2-acetamido-4-methyl-1,3-thiazol-5-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(NC(=O)C)=NC(C)=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 MTVCHEWHEXHTEZ-UHFFFAOYSA-N 0.000 description 1
- KTAANUUUPDFXQF-UHFFFAOYSA-N 3-[(2-aminophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound NC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 KTAANUUUPDFXQF-UHFFFAOYSA-N 0.000 description 1
- ODAAXAHLDUAIKF-UHFFFAOYSA-N 3-[(2-bromo-4-chlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Br ODAAXAHLDUAIKF-UHFFFAOYSA-N 0.000 description 1
- MELIEJQIWWYFQN-UHFFFAOYSA-N 3-[(2-bromo-4-methylbenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1Br MELIEJQIWWYFQN-UHFFFAOYSA-N 0.000 description 1
- YKZGSNZSVUIBAG-UHFFFAOYSA-N 3-[(2-carboxy-5-phenylthiophen-3-yl)-(2,4-dichlorobenzoyl)amino]pyrrolidine-1-carboxylic acid Chemical compound C1N(C(=O)O)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl YKZGSNZSVUIBAG-UHFFFAOYSA-N 0.000 description 1
- LEHSVMJJURFWBI-UHFFFAOYSA-N 3-[(2-chlorobenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=CC=C1Cl LEHSVMJJURFWBI-UHFFFAOYSA-N 0.000 description 1
- SHSKYMKVNOTZRL-UHFFFAOYSA-N 3-[(2-chlorophenyl)methyl-(cyclobutanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CCC1)CC1=CC=CC=C1Cl SHSKYMKVNOTZRL-UHFFFAOYSA-N 0.000 description 1
- FMZCSMZWRYPRDM-UHFFFAOYSA-N 3-[(2-cyano-4-methylbenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1C#N FMZCSMZWRYPRDM-UHFFFAOYSA-N 0.000 description 1
- DDVATQZXPFIULN-UHFFFAOYSA-N 3-[(2-cyclopentylacetyl)-[(3-methylphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC(CN(C(=O)CC2CCCC2)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1 DDVATQZXPFIULN-UHFFFAOYSA-N 0.000 description 1
- HMXBMUPYEYJJJE-UHFFFAOYSA-N 3-[(2-ethenyl-4-methylbenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1C=C HMXBMUPYEYJJJE-UHFFFAOYSA-N 0.000 description 1
- OHWKSFRFMPTNNI-UHFFFAOYSA-N 3-[(2-ethenylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1C=C OHWKSFRFMPTNNI-UHFFFAOYSA-N 0.000 description 1
- RBRIBDVYHLVUON-UHFFFAOYSA-N 3-[(2-fluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1F RBRIBDVYHLVUON-UHFFFAOYSA-N 0.000 description 1
- WLANPLOSJUTPJY-UHFFFAOYSA-N 3-[(2-methoxy-4-methylbenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound COC1=CC(C)=CC=C1C(=O)N(C)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 WLANPLOSJUTPJY-UHFFFAOYSA-N 0.000 description 1
- XRRFVOWNVSQMAS-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(1h-pyrazol-5-yl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C2=NNC=C2)=C1 XRRFVOWNVSQMAS-UHFFFAOYSA-N 0.000 description 1
- XRDCXQCYMYCWEQ-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(2-phenylethynyl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C#CC=2C=CC=CC=2)=C1 XRDCXQCYMYCWEQ-UHFFFAOYSA-N 0.000 description 1
- MOOICDKRFYICTE-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-[3-(trifluoromethoxy)phenyl]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(OC(F)(F)F)C=CC=2)=C1 MOOICDKRFYICTE-UHFFFAOYSA-N 0.000 description 1
- IUDGMSSOAPPGCL-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-pyridin-2-ylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2N=CC=CC=2)=C1 IUDGMSSOAPPGCL-UHFFFAOYSA-N 0.000 description 1
- KUTYVKIVEHCFFR-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-quinolin-8-ylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C3=NC=CC=C3C=CC=2)=C1 KUTYVKIVEHCFFR-UHFFFAOYSA-N 0.000 description 1
- TWXUHBNGDZBSBM-UHFFFAOYSA-N 3-[(3,4-dimethoxybenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)N(C)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 TWXUHBNGDZBSBM-UHFFFAOYSA-N 0.000 description 1
- RCMSCOKJKCOJIC-UHFFFAOYSA-N 3-[(3-cyclopentyl-3-oxopropyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCCC(=O)C1CCCC1 RCMSCOKJKCOJIC-UHFFFAOYSA-N 0.000 description 1
- WBYYVLDPSBBWFU-UHFFFAOYSA-N 3-[(3-methoxyphenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound COC1=CC=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC(CC(C)C)=CC=2)C(O)=O)=C1 WBYYVLDPSBBWFU-UHFFFAOYSA-N 0.000 description 1
- OMRAXNSXGUIYRC-UHFFFAOYSA-N 3-[(3-methylphenyl)methyl-(2-methylpropanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)C(C)C)CC1=CC=CC(C)=C1 OMRAXNSXGUIYRC-UHFFFAOYSA-N 0.000 description 1
- AVLUOOBKRNWXAE-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxamide Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(N)=O)=C1C AVLUOOBKRNWXAE-UHFFFAOYSA-N 0.000 description 1
- YDZCKMDOWRWMGU-UHFFFAOYSA-N 3-[(4-chloro-2-methylbenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1C YDZCKMDOWRWMGU-UHFFFAOYSA-N 0.000 description 1
- YQAWXTUILIXDBJ-UHFFFAOYSA-N 3-[(4-chloro-2-nitrobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1[N+]([O-])=O YQAWXTUILIXDBJ-UHFFFAOYSA-N 0.000 description 1
- DTJXFJMZNCGOHZ-UHFFFAOYSA-N 3-[(4-chlorocyclohexanecarbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(Cl)CC1 DTJXFJMZNCGOHZ-UHFFFAOYSA-N 0.000 description 1
- KTPKHNIYXBYFFK-UHFFFAOYSA-N 3-[(4-chlorophenoxy)carbonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)OC1=CC=C(Cl)C=C1 KTPKHNIYXBYFFK-UHFFFAOYSA-N 0.000 description 1
- MZVKUALIGZNGRV-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl-(2-cyclopentylacetyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)CC1CCCC1)CC1=CC=C(Cl)C=C1 MZVKUALIGZNGRV-UHFFFAOYSA-N 0.000 description 1
- WQJNEKIAYOYNDU-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl-(cyclobutanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CCC1)CC1=CC=C(Cl)C=C1 WQJNEKIAYOYNDU-UHFFFAOYSA-N 0.000 description 1
- AVYQXHXHISFQKR-UHFFFAOYSA-N 3-[(4-chlorophenyl)methyl-propanoylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC)CC1=CC=C(Cl)C=C1 AVYQXHXHISFQKR-UHFFFAOYSA-N 0.000 description 1
- AAVZCKQSUQKSOY-UHFFFAOYSA-N 3-[(4-ethylcyclohexanecarbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CC(CC)CCC1C(=O)N(C(C)C)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 AAVZCKQSUQKSOY-UHFFFAOYSA-N 0.000 description 1
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 description 1
- WSSSMLQSLMBZLL-UHFFFAOYSA-N 3-[(4-methylbenzoyl)-(3-methylbut-2-enyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC=C(C)C)C(=O)C1=CC=C(C)C=C1 WSSSMLQSLMBZLL-UHFFFAOYSA-N 0.000 description 1
- RPIJHSUWCVNLHD-UHFFFAOYSA-N 3-[(4-methylbenzoyl)-piperidin-4-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C1CCNCC1 RPIJHSUWCVNLHD-UHFFFAOYSA-N 0.000 description 1
- NZTSRVXQZUZJAA-UHFFFAOYSA-N 3-[(4-methylcyclohexanecarbonyl)-pyridin-4-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CC(C)CCC1C(=O)N(C=1C=CN=CC=1)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 NZTSRVXQZUZJAA-UHFFFAOYSA-N 0.000 description 1
- FAOVOPXOPFMDLA-UHFFFAOYSA-N 3-[(4-pentylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 FAOVOPXOPFMDLA-UHFFFAOYSA-N 0.000 description 1
- DWLCWYANOKPLKD-UHFFFAOYSA-N 3-[(5-carboxy-4-chloro-2-fluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC(C(O)=O)=C(Cl)C=C1F DWLCWYANOKPLKD-UHFFFAOYSA-N 0.000 description 1
- KWKLELHEDRQURA-UHFFFAOYSA-N 3-[(5-chlorothiophen-2-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(Cl)S1 KWKLELHEDRQURA-UHFFFAOYSA-N 0.000 description 1
- UMKOYEADQOBGPL-UHFFFAOYSA-N 3-[(6-chloropyridine-3-carbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)N=C1 UMKOYEADQOBGPL-UHFFFAOYSA-N 0.000 description 1
- RQFGVYRDVDMKEX-UHFFFAOYSA-N 3-[1-methoxypropan-2-yl-(4-methylcyclohexanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)COC)C(=O)C1CCC(C)CC1 RQFGVYRDVDMKEX-UHFFFAOYSA-N 0.000 description 1
- BGAJNPLDJJBRHK-UHFFFAOYSA-N 3-[2-[5-(3-chloro-4-propan-2-yloxyphenyl)-1,3,4-thiadiazol-2-yl]-3-methyl-6,7-dihydro-4h-pyrazolo[4,3-c]pyridin-5-yl]propanoic acid Chemical compound C1=C(Cl)C(OC(C)C)=CC=C1C1=NN=C(N2C(=C3CN(CCC(O)=O)CCC3=N2)C)S1 BGAJNPLDJJBRHK-UHFFFAOYSA-N 0.000 description 1
- ISWKLMHNNGWPQG-UHFFFAOYSA-N 3-[3-cyclopentylpropanoyl(ethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC)C(=O)CCC1CCCC1 ISWKLMHNNGWPQG-UHFFFAOYSA-N 0.000 description 1
- QZQKZKQXLNZBPC-UHFFFAOYSA-N 3-[3-methylbutanoyl-[[4-(trifluoromethyl)phenyl]methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC(C)C)CC1=CC=C(C(F)(F)F)C=C1 QZQKZKQXLNZBPC-UHFFFAOYSA-N 0.000 description 1
- VASWYPJCUJYIHG-UHFFFAOYSA-N 3-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=C(C(O)=O)SC=C1 VASWYPJCUJYIHG-UHFFFAOYSA-N 0.000 description 1
- TZZDVPMABRWKIZ-MFTLXVFQSA-N 3-[6-[4-[[1-[4-[(1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl]phenyl]piperidin-4-yl]methyl]piperazin-1-yl]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione Chemical compound OC=1C=C2CC[C@@H]([C@@H](C2=CC=1)C1=CC=C(C=C1)N1CCC(CC1)CN1CCN(CC1)C=1C=C2CN(C(C2=CC=1)=O)C1C(NC(CC1)=O)=O)C1=CC=CC=C1 TZZDVPMABRWKIZ-MFTLXVFQSA-N 0.000 description 1
- XDZHFMJXCOKCNO-KYJSFNMBSA-N 3-[[(1r,2s,4r)-2-hydroxy-4-methylcyclohexanecarbonyl]-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)[C@@H]1CC[C@@H](C)C[C@@H]1O XDZHFMJXCOKCNO-KYJSFNMBSA-N 0.000 description 1
- CJBPLFJQSDNYFN-UHFFFAOYSA-N 3-[[1-[tert-butyl(dimethyl)silyl]oxy-1-phenylpropan-2-yl]-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(C)C(O[Si](C)(C)C(C)(C)C)C1=CC=CC=C1 CJBPLFJQSDNYFN-UHFFFAOYSA-N 0.000 description 1
- XLXYLLVQQSLUQN-UHFFFAOYSA-N 3-[[2,5-bis(2,2,2-trifluoroethoxy)phenyl]sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F XLXYLLVQQSLUQN-UHFFFAOYSA-N 0.000 description 1
- XEBRMGWQOAMEJD-UHFFFAOYSA-N 3-[[2-(4-methoxyphenyl)acetyl]-prop-2-enylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1CC(=O)N(CC=C)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 XEBRMGWQOAMEJD-UHFFFAOYSA-N 0.000 description 1
- TVZQQBXPOAOCMB-UHFFFAOYSA-N 3-[[3-(1-benzofuran-2-yl)phenyl]methyl-(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)N(CC=2C=C(C=CC=2)C=2OC3=CC=CC=C3C=2)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1C TVZQQBXPOAOCMB-UHFFFAOYSA-N 0.000 description 1
- DNIXZRHEQWSRJZ-UHFFFAOYSA-N 3-[[4-(2-oxo-3h-benzimidazol-1-yl)piperidine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C(NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C32)=O)=C(C(=O)O)SC=1C1=CC=CC=C1 DNIXZRHEQWSRJZ-UHFFFAOYSA-N 0.000 description 1
- LGPLBTLUERBRNW-UHFFFAOYSA-N 3-[[4-(4-nitrophenyl)piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)N(CC1)CCN1C1=CC=C([N+]([O-])=O)C=C1 LGPLBTLUERBRNW-UHFFFAOYSA-N 0.000 description 1
- OETHKSLBGKXPAZ-UHFFFAOYSA-N 3-[[4-(6-methylpyridin-2-yl)piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid;hydrochloride Chemical compound Cl.CC1=CC=CC(N2CCN(CC2)C(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=N1 OETHKSLBGKXPAZ-UHFFFAOYSA-N 0.000 description 1
- QFBMDPVMURRDJA-UHFFFAOYSA-N 3-[benzyl(3-methylbutanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC(C)C)CC1=CC=CC=C1 QFBMDPVMURRDJA-UHFFFAOYSA-N 0.000 description 1
- ITAXGIVXOBBIGO-UHFFFAOYSA-N 3-[benzyl(propanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC)CC1=CC=CC=C1 ITAXGIVXOBBIGO-UHFFFAOYSA-N 0.000 description 1
- RSOWMXDODPAJPL-UHFFFAOYSA-N 3-[benzyl-(2-cyclopentylacetyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)CC1CCCC1)CC1=CC=CC=C1 RSOWMXDODPAJPL-UHFFFAOYSA-N 0.000 description 1
- SIIMIVJATFOKHR-UHFFFAOYSA-N 3-[benzyl-(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)CC1=CC=CC=C1 SIIMIVJATFOKHR-UHFFFAOYSA-N 0.000 description 1
- OMMRCJMTUFZTIB-UHFFFAOYSA-N 3-[but-2-enoyl(ethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C(=O)C=CC)CC)C=C1C1=CC=CC=C1 OMMRCJMTUFZTIB-UHFFFAOYSA-N 0.000 description 1
- PWPCCXSZLFVANL-UHFFFAOYSA-N 3-[butanoyl(ethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(CC)C(=O)CCC)C=C1C1=CC=CC=C1 PWPCCXSZLFVANL-UHFFFAOYSA-N 0.000 description 1
- ADVRSLHZOIHULA-UHFFFAOYSA-N 3-[butanoyl-[(3-methoxyphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CCC)CC1=CC=CC(OC)=C1 ADVRSLHZOIHULA-UHFFFAOYSA-N 0.000 description 1
- LKCDNLLGGTXLGO-UHFFFAOYSA-N 3-[butanoyl-[(4-tert-butylphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CCC)CC1=CC=C(C(C)(C)C)C=C1 LKCDNLLGGTXLGO-UHFFFAOYSA-N 0.000 description 1
- IYWUNLSGBHHJMS-UHFFFAOYSA-N 3-[cyclobutanecarbonyl-[(2,4-difluorophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CCC1)CC1=CC=C(F)C=C1F IYWUNLSGBHHJMS-UHFFFAOYSA-N 0.000 description 1
- JODZOJIVVZXQBC-UHFFFAOYSA-N 3-[cyclohexanecarbonyl(propan-2-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCCCC1 JODZOJIVVZXQBC-UHFFFAOYSA-N 0.000 description 1
- JNMLHKVIANKLAW-UHFFFAOYSA-N 3-[cyclohexanecarbonyl-[(2,4-difluorophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CCCCC1)CC1=CC=C(F)C=C1F JNMLHKVIANKLAW-UHFFFAOYSA-N 0.000 description 1
- KURHJUIVGOCUAP-UHFFFAOYSA-N 3-[cyclohexanecarbonyl-[[4-(trifluoromethyl)phenyl]methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CCCCC1)CC1=CC=C(C(F)(F)F)C=C1 KURHJUIVGOCUAP-UHFFFAOYSA-N 0.000 description 1
- ARHDRKYFEBMWHM-UHFFFAOYSA-N 3-[cyclohexyl-(4-methylcyclohexanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CC(C)CCC1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C1CCCCC1 ARHDRKYFEBMWHM-UHFFFAOYSA-N 0.000 description 1
- JKZZIRPULQQELF-UHFFFAOYSA-N 3-[ethyl(hexanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(CC)C(=O)CCCCC)C=C1C1=CC=CC=C1 JKZZIRPULQQELF-UHFFFAOYSA-N 0.000 description 1
- RWQSABWWSQCRRJ-UHFFFAOYSA-N 3-[methyl(pentanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C)C(=O)CCCC)C=C1C1=CC=CC=C1 RWQSABWWSQCRRJ-UHFFFAOYSA-N 0.000 description 1
- JNWCUCLQFPDAPJ-UHFFFAOYSA-N 3-[methyl-(2,4,6-trifluorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=C(F)C=C(F)C=C1F JNWCUCLQFPDAPJ-UHFFFAOYSA-N 0.000 description 1
- DPQPHJGUMVATDP-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]-5-(2-methylphenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C(=CC=CC=2)C)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 DPQPHJGUMVATDP-UHFFFAOYSA-N 0.000 description 1
- RXXPNAARIJWCAO-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]-5-[3-(trifluoromethyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 RXXPNAARIJWCAO-UHFFFAOYSA-N 0.000 description 1
- KNEVFAXLOQHQSZ-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]-5-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(OC(F)(F)F)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 KNEVFAXLOQHQSZ-UHFFFAOYSA-N 0.000 description 1
- JGZPYYREBSYWHY-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 JGZPYYREBSYWHY-UHFFFAOYSA-N 0.000 description 1
- IZHUPPBRYPCMKI-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=CSC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 IZHUPPBRYPCMKI-UHFFFAOYSA-N 0.000 description 1
- ISTOHGVTGKRKOC-UHFFFAOYSA-N 3-[methyl-(4-methylcyclohexanecarbonyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CC(C)CCC1C(=O)N(C)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 ISTOHGVTGKRKOC-UHFFFAOYSA-N 0.000 description 1
- SSDCAEYAPMSGEI-UHFFFAOYSA-N 3-[methyl-(4-methylphenyl)carbamoyl]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=C(C)C=CC=1N(C)C(=O)C(=C(S1)C(O)=O)C=C1C1=CC=CC=C1 SSDCAEYAPMSGEI-UHFFFAOYSA-N 0.000 description 1
- USEGQJLHQSTGHW-UHFFFAOYSA-N 3-bromo-2-methylprop-1-ene Chemical compound CC(=C)CBr USEGQJLHQSTGHW-UHFFFAOYSA-N 0.000 description 1
- WBUOVKBZJOIOAE-UHFFFAOYSA-N 3-chlorobenzonitrile Chemical compound ClC1=CC=CC(C#N)=C1 WBUOVKBZJOIOAE-UHFFFAOYSA-N 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- UDUXURAIZKMFMJ-UHFFFAOYSA-N 3-methylcyclopent-3-ene-1-carboxylic acid Chemical compound CC1=CCC(C(O)=O)C1 UDUXURAIZKMFMJ-UHFFFAOYSA-N 0.000 description 1
- WGYFINWERLNPHR-UHFFFAOYSA-N 3-nitroanisole Chemical compound COC1=CC=CC([N+]([O-])=O)=C1 WGYFINWERLNPHR-UHFFFAOYSA-N 0.000 description 1
- 125000006490 3-t-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006495 3-trifluoromethyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])*)C(F)(F)F 0.000 description 1
- JPYLQQLSCQCPMW-UHFFFAOYSA-N 4-[(2,4-dichlorobenzoyl)-(2-methoxycarbonyl-5-phenylthiophen-3-yl)amino]piperidine-1-carboxylic acid Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CCN(C(O)=O)CC1 JPYLQQLSCQCPMW-UHFFFAOYSA-N 0.000 description 1
- CSIHZUJSKGJFAR-UHFFFAOYSA-N 4-[[(2-carboxy-5-phenylthiophen-3-yl)-(2,4-dichlorobenzoyl)amino]methyl]piperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1CN(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl CSIHZUJSKGJFAR-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- DQAZPZIYEOGZAF-UHFFFAOYSA-N 4-ethyl-n-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]piperazine-1-carboxamide Chemical compound C1CN(CC)CCN1C(=O)NC(C(=CC1=NC=N2)OC)=CC1=C2NC1=CC=CC(C#C)=C1 DQAZPZIYEOGZAF-UHFFFAOYSA-N 0.000 description 1
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
- ODYARUXXIJYYNA-UHFFFAOYSA-N 4-methylcyclohexane-1-carbonyl chloride Chemical compound CC1CCC(C(Cl)=O)CC1 ODYARUXXIJYYNA-UHFFFAOYSA-N 0.000 description 1
- SEJLNASIMOIFEW-UHFFFAOYSA-N 5-(3,4-difluorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(F)C(F)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 SEJLNASIMOIFEW-UHFFFAOYSA-N 0.000 description 1
- APDZFMJREYOVST-UHFFFAOYSA-N 5-(3-acetamidophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC(=O)NC1=CC=CC(C=2SC(=C(NS(=O)(=O)C=3C(=CC=CC=3)C)C=2)C(O)=O)=C1 APDZFMJREYOVST-UHFFFAOYSA-N 0.000 description 1
- BLBHOCKMZJYRIO-UHFFFAOYSA-N 5-(3-acetylphenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)C(C)=O)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 BLBHOCKMZJYRIO-UHFFFAOYSA-N 0.000 description 1
- SEAVSOGFBAOHPL-UHFFFAOYSA-N 5-(3-aminophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(N)C=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 SEAVSOGFBAOHPL-UHFFFAOYSA-N 0.000 description 1
- PKBKDFZIMMBBAM-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(Cl)C=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl PKBKDFZIMMBBAM-UHFFFAOYSA-N 0.000 description 1
- TXHKXXHEVSHJJF-UHFFFAOYSA-N 5-(3-hydroxyphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(O)C=CC=2)=C1 TXHKXXHEVSHJJF-UHFFFAOYSA-N 0.000 description 1
- ABVJKSFWGVLUSX-UHFFFAOYSA-N 5-(3-hydroxyphenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(O)C=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 ABVJKSFWGVLUSX-UHFFFAOYSA-N 0.000 description 1
- MLUKPFFOQOKWOG-UHFFFAOYSA-N 5-(3-methoxyphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound COC1=CC=CC(C=2SC(=C(NS(=O)(=O)C=3C(=CC=CC=3)C)C=2)C(O)=O)=C1 MLUKPFFOQOKWOG-UHFFFAOYSA-N 0.000 description 1
- XOAIVGFWKMGZLO-UHFFFAOYSA-N 5-(4-acetylphenyl)-3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(=CC=2)C(C)=O)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl XOAIVGFWKMGZLO-UHFFFAOYSA-N 0.000 description 1
- PNHBHRJXTYBQFC-UHFFFAOYSA-N 5-(4-aminophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(N)=CC=2)=C1 PNHBHRJXTYBQFC-UHFFFAOYSA-N 0.000 description 1
- FFHMRBNBOZMIGR-UHFFFAOYSA-N 5-(4-aminophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(N)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 FFHMRBNBOZMIGR-UHFFFAOYSA-N 0.000 description 1
- BXAUXTLBBGYWHM-UHFFFAOYSA-N 5-(4-carbamoylphenyl)-3-[(4-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)C(N)=O)=C1 BXAUXTLBBGYWHM-UHFFFAOYSA-N 0.000 description 1
- LBIVPWRLCKPEEU-UHFFFAOYSA-N 5-(4-carboxyphenyl)-3-[(2,4-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)C(O)=O)=C1 LBIVPWRLCKPEEU-UHFFFAOYSA-N 0.000 description 1
- WCORMCARGXHGLI-UHFFFAOYSA-N 5-(4-chlorophenyl)-3-(pyridin-2-ylsulfonylamino)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC(Cl)=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=N1 WCORMCARGXHGLI-UHFFFAOYSA-N 0.000 description 1
- AUIBRZIOXIGUOX-UHFFFAOYSA-N 5-(4-chlorophenyl)-3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(Cl)=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1 AUIBRZIOXIGUOX-UHFFFAOYSA-N 0.000 description 1
- OHRNKGSYCCKGQI-UHFFFAOYSA-N 5-(4-chlorophenyl)-3-[(4-methylphenyl)sulfonylamino]thiophene-2-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(N)=O)SC(C=2C=CC(Cl)=CC=2)=C1 OHRNKGSYCCKGQI-UHFFFAOYSA-N 0.000 description 1
- YOHJNQVVESOXDQ-UHFFFAOYSA-N 5-(4-chlorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(Cl)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 YOHJNQVVESOXDQ-UHFFFAOYSA-N 0.000 description 1
- RYXAHMSZLLIPRO-UHFFFAOYSA-N 5-(4-cyanophenyl)-3-{[(2-methylphenyl)sulfonyl]amino}thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)C#N)=C1 RYXAHMSZLLIPRO-UHFFFAOYSA-N 0.000 description 1
- RIDSARHTSRIIMT-UHFFFAOYSA-N 5-(4-ethylphenyl)-3-[(2-hydroxy-4-methylbenzoyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(CC)=CC=C1C1=CC(N(C(C)C)C(=O)C=2C(=CC(C)=CC=2)O)=C(C(O)=O)S1 RIDSARHTSRIIMT-UHFFFAOYSA-N 0.000 description 1
- GONUYTKDLXINGO-UHFFFAOYSA-N 5-(4-ethylphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=CC(CC)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC=CC=2)C)=C(C(O)=O)S1 GONUYTKDLXINGO-UHFFFAOYSA-N 0.000 description 1
- CQJRGESCDMIWCA-UHFFFAOYSA-N 5-(4-fluorophenyl)-3-(pyridin-2-ylsulfonylamino)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC(F)=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=N1 CQJRGESCDMIWCA-UHFFFAOYSA-N 0.000 description 1
- IIUFZSJTEUQEQD-UHFFFAOYSA-N 5-(4-fluorophenyl)-3-[(4-methylbenzoyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(F)=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1 IIUFZSJTEUQEQD-UHFFFAOYSA-N 0.000 description 1
- OMNZOAJDBLOFIA-UHFFFAOYSA-N 5-(4-fluorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(F)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 OMNZOAJDBLOFIA-UHFFFAOYSA-N 0.000 description 1
- WITUCJBPBKKQCP-UHFFFAOYSA-N 5-(4-hydroxyphenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(O)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 WITUCJBPBKKQCP-UHFFFAOYSA-N 0.000 description 1
- MSTQDDVCLJZYFZ-UHFFFAOYSA-N 5-(4-methoxyphenyl)-3-[(4-methylphenyl)sulfonylamino]thiophene-2-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=CC(NS(=O)(=O)C=2C=CC(C)=CC=2)=C(C(N)=O)S1 MSTQDDVCLJZYFZ-UHFFFAOYSA-N 0.000 description 1
- URGNYFYUEOKCII-UHFFFAOYSA-N 5-[(3-cyanophenyl)methyl]-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(CC=2C=C(C=CC=2)C#N)=C1 URGNYFYUEOKCII-UHFFFAOYSA-N 0.000 description 1
- JMFWGXZBONIYER-UHFFFAOYSA-N 5-[2-(4-chlorophenyl)ethenyl]-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=CC=2C=CC(Cl)=CC=2)=C1 JMFWGXZBONIYER-UHFFFAOYSA-N 0.000 description 1
- BECHPBVVELWRBW-UHFFFAOYSA-N 5-[2-(trifluoromethyl)phenyl]furan-2-carbaldehyde Chemical compound FC(F)(F)C1=CC=CC=C1C1=CC=C(C=O)O1 BECHPBVVELWRBW-UHFFFAOYSA-N 0.000 description 1
- FUJIGVKGWFWWHD-UHFFFAOYSA-N 5-bromo-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(Br)=C1 FUJIGVKGWFWWHD-UHFFFAOYSA-N 0.000 description 1
- UBLCLJAKLXHOCN-UHFFFAOYSA-N 5-bromo-3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(Br)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1 UBLCLJAKLXHOCN-UHFFFAOYSA-N 0.000 description 1
- BADLZVZNMSEXRJ-UHFFFAOYSA-N 5-ethynyl-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C#C)=C1 BADLZVZNMSEXRJ-UHFFFAOYSA-N 0.000 description 1
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 description 1
- WRSGCWMVJVEOBX-UHFFFAOYSA-N 5-phenyl-3-(3-phenylpropylcarbamoylamino)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)NCCCC1=CC=CC=C1 WRSGCWMVJVEOBX-UHFFFAOYSA-N 0.000 description 1
- CAYQRBRUSWVAIG-UHFFFAOYSA-N 5-phenyl-3-[(2,3,4-trichlorophenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(Cl)C(Cl)=C1Cl CAYQRBRUSWVAIG-UHFFFAOYSA-N 0.000 description 1
- UPKURVCPFZPIBU-UHFFFAOYSA-N 5-phenyl-3-[(2,4,6-trimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 UPKURVCPFZPIBU-UHFFFAOYSA-N 0.000 description 1
- POQLKLBEPAFHSO-UHFFFAOYSA-N 5-phenyl-3-[[5-(trifluoromethyl)pyridin-2-yl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(C(F)(F)F)C=N1 POQLKLBEPAFHSO-UHFFFAOYSA-N 0.000 description 1
- MOESMOWSZWYBHB-UHFFFAOYSA-N 5-phenyl-3-[propan-2-yl-(2,4,6-trimethylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=C(C)C=C(C)C=C1C MOESMOWSZWYBHB-UHFFFAOYSA-N 0.000 description 1
- XYLNZOAREJPJIH-UHFFFAOYSA-N 5-phenylthiophene-2,3-dicarboxylic acid Chemical compound S1C(C(O)=O)=C(C(=O)O)C=C1C1=CC=CC=C1 XYLNZOAREJPJIH-UHFFFAOYSA-N 0.000 description 1
- HBZVNWNSRNTWPS-UHFFFAOYSA-N 6-amino-4-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C(O)C2=CC(N)=CC=C21 HBZVNWNSRNTWPS-UHFFFAOYSA-N 0.000 description 1
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 1
- ZAFXSUMTLFTRLZ-UHFFFAOYSA-N 6-phenyl-1h-thieno[3,2-d][1,3]oxazine-2,4-dione Chemical compound S1C=2C(=O)OC(=O)NC=2C=C1C1=CC=CC=C1 ZAFXSUMTLFTRLZ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- RBMMYPCWFPSQQQ-UHFFFAOYSA-N 8-chloro-3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-4h-thieno[3,2-c]thiochromene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC=3C4=CC(Cl)=CC=C4SCC=32)C(O)=O)=C1C RBMMYPCWFPSQQQ-UHFFFAOYSA-N 0.000 description 1
- 238000006064 ATPase reaction Methods 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 241000282421 Canidae Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102100032373 Coiled-coil domain-containing protein 85B Human genes 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- PTVSRINJXWDIKP-UHFFFAOYSA-N Ethyl 4-pentenoate Chemical compound CCOC(=O)CCC=C PTVSRINJXWDIKP-UHFFFAOYSA-N 0.000 description 1
- 241000400611 Eucalyptus deanei Species 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- RRSNDVCODIMOFX-MPKOGUQCSA-N Fc1c(Cl)cccc1[C@H]1[C@@H](NC2(CCCCC2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)Nc1ccc(cc1)C(=O)NCCCCCc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O Chemical compound Fc1c(Cl)cccc1[C@H]1[C@@H](NC2(CCCCC2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)Nc1ccc(cc1)C(=O)NCCCCCc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O RRSNDVCODIMOFX-MPKOGUQCSA-N 0.000 description 1
- 206010057199 Flaviviral infections Diseases 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000007821 HATU Substances 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101000868814 Homo sapiens Coiled-coil domain-containing protein 85B Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- YAMHWTCZBZTUKT-UHFFFAOYSA-N N-chloro-2-fluorobenzenesulfonamide Chemical compound FC1=CC=CC=C1S(=O)(=O)NCl YAMHWTCZBZTUKT-UHFFFAOYSA-N 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 101800001020 Non-structural protein 4A Proteins 0.000 description 1
- 101800001019 Non-structural protein 4B Proteins 0.000 description 1
- 101800001014 Non-structural protein 5A Proteins 0.000 description 1
- MIZIXHLLYNBOCW-UHFFFAOYSA-N OCCNC(=O)C=1SC(=CC=1)C1=CC=CC=C1 Chemical compound OCCNC(=O)C=1SC(=CC=1)C1=CC=CC=C1 MIZIXHLLYNBOCW-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000710778 Pestivirus Species 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101800001838 Serine protease/helicase NS3 Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000907663 Siproeta stelenes Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 101100343203 Vigna unguiculata LBII gene Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- FABPASRXDSSEPV-VDAHYXPESA-N [(1s,2r,5r)-2-carbonochloridoyl-5-methylcyclohexyl] acetate Chemical compound C[C@@H]1CC[C@@H](C(Cl)=O)[C@@H](OC(C)=O)C1 FABPASRXDSSEPV-VDAHYXPESA-N 0.000 description 1
- SSZJQMZIHZOMLN-UHFFFAOYSA-N [4-[(2-carboxy-5-phenylthiophen-3-yl)-(2,4-dichlorobenzoyl)amino]cyclohexyl]azanium 2,2,2-trifluoroacetate Chemical compound FC(C(=O)[O-])(F)F.C(=O)(O)C=1SC(=CC1N(C1CCC(CC1)[NH3+])C(C1=C(C=C(C=C1)Cl)Cl)=O)C1=CC=CC=C1 SSZJQMZIHZOMLN-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- WFKAJVHLWXSISD-UHFFFAOYSA-N anhydrous dimethyl-acetamide Natural products CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- YNCYPMUJDDXIRH-UHFFFAOYSA-N benzo[b]thiophene-2-boronic acid Chemical compound C1=CC=C2SC(B(O)O)=CC2=C1 YNCYPMUJDDXIRH-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- GMXVCKYSCSAAPL-UHFFFAOYSA-N benzyl 4-[[(2,4-dichlorobenzoyl)-(2-methoxycarbonyl-5-phenylthiophen-3-yl)amino]methyl]piperidine-1-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)CC(CC1)CCN1C(=O)OCC1=CC=CC=C1 GMXVCKYSCSAAPL-UHFFFAOYSA-N 0.000 description 1
- VFLMJXIZPDYXOD-UHFFFAOYSA-N benzyl 4-[[(2-methoxycarbonyl-5-phenylthiophen-3-yl)amino]methyl]piperidine-1-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCC(CC1)CCN1C(=O)OCC1=CC=CC=C1 VFLMJXIZPDYXOD-UHFFFAOYSA-N 0.000 description 1
- ZJQMLJFHCKTCSF-UHFFFAOYSA-N benzyl 4-formylpiperidine-1-carboxylate Chemical compound C1CC(C=O)CCN1C(=O)OCC1=CC=CC=C1 ZJQMLJFHCKTCSF-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229960004424 carbon dioxide Drugs 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 125000004803 chlorobenzyl group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 229940126545 compound 53 Drugs 0.000 description 1
- 229940127113 compound 57 Drugs 0.000 description 1
- 229940125900 compound 59 Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- ZIQIQOUPRHPOIT-UHFFFAOYSA-N cyclobutylazanide Chemical compound [NH-]C1CCC1 ZIQIQOUPRHPOIT-UHFFFAOYSA-N 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- ZOOSILUVXHVRJE-UHFFFAOYSA-N cyclopropanecarbonyl chloride Chemical compound ClC(=O)C1CC1 ZOOSILUVXHVRJE-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- KVBKAPANDHPRDG-UHFFFAOYSA-N dibromotetrafluoroethane Chemical compound FC(F)(Br)C(F)(F)Br KVBKAPANDHPRDG-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-O diethylammonium Chemical compound CC[NH2+]CC HPNMFZURTQLUMO-UHFFFAOYSA-O 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- COQRGFWWJBEXRC-UHFFFAOYSA-N hydron;methyl 2-aminoacetate;chloride Chemical compound Cl.COC(=O)CN COQRGFWWJBEXRC-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- LBGLFEUKGFLLOB-UHFFFAOYSA-M lithium;3-[(4-methylcyclohexanecarbonyl)-piperidin-4-ylamino]-5-phenylthiophene-2-carboxylate Chemical compound [Li+].C1CC(C)CCC1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C([O-])=O)C1CCNCC1 LBGLFEUKGFLLOB-UHFFFAOYSA-M 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 125000003564 m-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(C#N)=C1[H])C([H])([H])* 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- BQPWNGSOMKFPHO-UHFFFAOYSA-N methyl 2-[[3-[(4-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carbonyl]amino]acetate Chemical compound COC(=O)CNC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(C)C=C1 BQPWNGSOMKFPHO-UHFFFAOYSA-N 0.000 description 1
- VBCUJLLZYNPHKV-UHFFFAOYSA-N methyl 3-(methylamino)-5-phenylthiophene-2-carboxylate Chemical compound S1C(C(=O)OC)=C(NC)C=C1C1=CC=CC=C1 VBCUJLLZYNPHKV-UHFFFAOYSA-N 0.000 description 1
- XWDSRIPTBNTXFE-UHFFFAOYSA-N methyl 3-[(1-methylpiperidin-4-yl)amino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC1CCN(C)CC1 XWDSRIPTBNTXFE-UHFFFAOYSA-N 0.000 description 1
- CLJPSYDWHVZAFT-UHFFFAOYSA-N methyl 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC(C)=C(Cl)C=C1C CLJPSYDWHVZAFT-UHFFFAOYSA-N 0.000 description 1
- JHKOADXDVOTEGS-BSIFCXSSSA-N methyl 3-[[(1r,2s,4r)-2-acetyloxy-4-methylcyclohexanecarbonyl]-propan-2-ylamino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(C)C)C(=O)[C@@H]1CC[C@@H](C)C[C@@H]1OC(C)=O JHKOADXDVOTEGS-BSIFCXSSSA-N 0.000 description 1
- VXLMKFFZHOWBTA-UHFFFAOYSA-N methyl 3-[benzoyl(methyl)amino]-5-phenylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C)C(=O)C1=CC=CC=C1 VXLMKFFZHOWBTA-UHFFFAOYSA-N 0.000 description 1
- WHJBGOQJMFAKHY-UHFFFAOYSA-N methyl 3-amino-5-tert-butylthiophene-2-carboxylate Chemical compound COC(=O)C=1SC(C(C)(C)C)=CC=1N WHJBGOQJMFAKHY-UHFFFAOYSA-N 0.000 description 1
- TWEQNZZOOFKOER-UHFFFAOYSA-N methyl 3-aminothiophene-2-carboxylate Chemical compound COC(=O)C=1SC=CC=1N TWEQNZZOOFKOER-UHFFFAOYSA-N 0.000 description 1
- HSLZXALEQUIDCT-UHFFFAOYSA-N methyl 3-bromo-5-phenylthiophene-2-carboxylate Chemical compound BrC1=C(C(=O)OC)SC(C=2C=CC=CC=2)=C1 HSLZXALEQUIDCT-UHFFFAOYSA-N 0.000 description 1
- LMZBRQAQSKHMCQ-UHFFFAOYSA-N methyl 4-[(4-methylcyclohexanecarbonyl)amino]-5-(3-methylphenyl)-3-propan-2-ylthiophene-2-carboxylate Chemical compound CC(C)C1=C(C(=O)OC)SC(C=2C=C(C)C=CC=2)=C1NC(=O)C1CCC(C)CC1 LMZBRQAQSKHMCQ-UHFFFAOYSA-N 0.000 description 1
- PBQQQIICHCMJIX-UHFFFAOYSA-N methyl 5-bromo-3-(propan-2-ylamino)thiophene-2-carboxylate Chemical compound COC(=O)C=1SC(Br)=CC=1NC(C)C PBQQQIICHCMJIX-UHFFFAOYSA-N 0.000 description 1
- FKSYKJKBAIOVLP-UHFFFAOYSA-N methyl 5-bromo-3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]thiophene-2-carboxylate Chemical compound S1C(Br)=CC(N(C(C)C)C(=O)C2CCC(C)CC2)=C1C(=O)OC FKSYKJKBAIOVLP-UHFFFAOYSA-N 0.000 description 1
- JPJVRWZASWWDQA-UHFFFAOYSA-N methyl 5-tert-butyl-3-[(2,4-dimethylphenyl)sulfonylamino]thiophene-2-carboxylate Chemical compound S1C(C(C)(C)C)=CC(NS(=O)(=O)C=2C(=CC(C)=CC=2)C)=C1C(=O)OC JPJVRWZASWWDQA-UHFFFAOYSA-N 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- OKBJVCWRESLMMD-UHFFFAOYSA-N methyl n-(4-methylphenyl)carbamate Chemical compound COC(=O)NC1=CC=C(C)C=C1 OKBJVCWRESLMMD-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- KWWBSIRMGBSOLW-UHFFFAOYSA-N n,n-dimethyl-3-trimethylstannylpyrazole-1-sulfonamide Chemical compound CN(C)S(=O)(=O)N1C=CC([Sn](C)(C)C)=N1 KWWBSIRMGBSOLW-UHFFFAOYSA-N 0.000 description 1
- RFYSRCRZAGKOIY-UHFFFAOYSA-N n,n-dimethylpyrazole-1-sulfonamide Chemical compound CN(C)S(=O)(=O)N1C=CC=N1 RFYSRCRZAGKOIY-UHFFFAOYSA-N 0.000 description 1
- YCJZWBZJSYLMPB-UHFFFAOYSA-N n-(2-chloropyrimidin-4-yl)-2,5-dimethyl-1-phenylimidazole-4-carboxamide Chemical compound CC=1N(C=2C=CC=CC=2)C(C)=NC=1C(=O)NC1=CC=NC(Cl)=N1 YCJZWBZJSYLMPB-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- RADGOBKLTHEUQO-UHFFFAOYSA-N ruthenium(4+) Chemical compound [Ru+4] RADGOBKLTHEUQO-UHFFFAOYSA-N 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 description 1
- 229960002218 sodium chlorite Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- BWYDBADHYPANCF-UHFFFAOYSA-M sodium;3-amino-5-phenylthiophene-2-carboxylate Chemical compound [Na+].S1C(C([O-])=O)=C(N)C=C1C1=CC=CC=C1 BWYDBADHYPANCF-UHFFFAOYSA-M 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000006514 viral protein processing Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29673101P | 2001-06-11 | 2001-06-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL367080A1 PL367080A1 (en) | 2005-02-21 |
| PL208713B1 true PL208713B1 (pl) | 2011-05-31 |
Family
ID=23143308
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL367080A PL208713B1 (pl) | 2001-06-11 | 2002-06-11 | Związek stanowiący pochodną tiofenu, kompozycja farmaceutyczna zawierająca taki związek i jego zastosowanie |
| PL395097A PL395097A1 (pl) | 2001-06-11 | 2002-06-11 | Sposób wytwarzania związku o wzorze A stanowiącego pochodną tiofenu |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL395097A PL395097A1 (pl) | 2001-06-11 | 2002-06-11 | Sposób wytwarzania związku o wzorze A stanowiącego pochodną tiofenu |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6881741B2 (enExample) |
| EP (3) | EP2363396A1 (enExample) |
| JP (2) | JP4544857B2 (enExample) |
| KR (1) | KR100900304B1 (enExample) |
| CN (2) | CN101624391A (enExample) |
| AP (1) | AP1753A (enExample) |
| AT (1) | ATE438637T1 (enExample) |
| AU (2) | AU2002344854B2 (enExample) |
| BR (1) | BR0210357A (enExample) |
| CA (1) | CA2450007C (enExample) |
| CY (1) | CY1109497T1 (enExample) |
| CZ (1) | CZ20033368A3 (enExample) |
| DE (1) | DE60233227D1 (enExample) |
| DK (1) | DK1401825T3 (enExample) |
| EA (1) | EA007484B1 (enExample) |
| ES (1) | ES2330313T3 (enExample) |
| MX (1) | MXPA03011452A (enExample) |
| NO (1) | NO331721B1 (enExample) |
| OA (1) | OA12622A (enExample) |
| PL (2) | PL208713B1 (enExample) |
| PT (1) | PT1401825E (enExample) |
| SI (1) | SI1401825T1 (enExample) |
| SK (1) | SK288015B6 (enExample) |
| WO (1) | WO2002100851A2 (enExample) |
| ZA (1) | ZA200309590B (enExample) |
Families Citing this family (133)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA007484B1 (ru) * | 2001-06-11 | 2006-10-27 | Вирокем Фарма Инк. | Соединения и способы лечения или предупреждения инфекций flavivirus |
| US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
| EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| US7166639B2 (en) * | 2001-10-04 | 2007-01-23 | Smithkline Beecham Corporation | NF-κB inhibitors |
| WO2003104218A1 (en) * | 2002-06-06 | 2003-12-18 | Smithkline Beecham Corporation | Nf-:b inhibitors |
| US7179836B2 (en) * | 2002-09-20 | 2007-02-20 | Smithkline Beecham Corporation | Chemical compounds |
| TW200418863A (en) * | 2002-10-17 | 2004-10-01 | Upjohn Co | Novel anthelmintic and insecticidal compositions |
| US20050075279A1 (en) | 2002-10-25 | 2005-04-07 | Boehringer Ingelheim International Gmbh | Macrocyclic peptides active against the hepatitis C virus |
| PT1569929E (pt) * | 2002-12-10 | 2010-06-18 | Virochem Pharma Inc | Compostos e métodos para o tratamento ou prevenção de infecções por flavivírus |
| US20040192707A1 (en) * | 2002-12-10 | 2004-09-30 | Laval Chan Chun Kong | Compounds and methods for the treatment or prevention of Flavivirus infections |
| WO2004052885A1 (en) * | 2002-12-10 | 2004-06-24 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| US7365094B2 (en) | 2002-12-23 | 2008-04-29 | 4Sc Ag | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| US7247736B2 (en) | 2002-12-23 | 2007-07-24 | 4Sc Ag | Method of identifying inhibitors of DHODH |
| NZ541382A (en) * | 2002-12-23 | 2009-04-30 | 4Sc Ag | Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| EP2033654B1 (en) | 2003-04-16 | 2012-05-16 | Bristol-Myers Squibb Company | Process for resolving a mixture of alkyl ester enantiomers using an enzyme |
| US7112601B2 (en) | 2003-09-11 | 2006-09-26 | Bristol-Myers Squibb Company | Cycloalkyl heterocycles for treating hepatitis C virus |
| OA13315A (en) | 2003-10-14 | 2007-04-13 | Intermune Inc | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication. |
| EP1944042A1 (en) * | 2003-10-27 | 2008-07-16 | Vertex Pharmceuticals Incorporated | Combinations for HCV treatment |
| EP1677827B1 (en) * | 2003-10-27 | 2008-12-10 | Vertex Pharmaceuticals Incorporated | Combinations for hcv treatment |
| DE10359791A1 (de) * | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Substituierte Thiophene |
| GB0500020D0 (en) | 2005-01-04 | 2005-02-09 | Novartis Ag | Organic compounds |
| SG184700A1 (en) | 2004-02-20 | 2012-10-30 | Boehringer Ingelheim Int | Viral polymerase inhibitors |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| DE102004061746A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Alkinyl-substituierte Thiophene |
| DE102005028077A1 (de) * | 2004-12-22 | 2006-07-13 | Aicuris Gmbh & Co. Kg | Alkinyl-substituierte Thiophene |
| HRP20150765T1 (hr) | 2004-12-30 | 2015-10-09 | Janssen Pharmaceutica N.V. | Amid derivati piperidin- i piperazin-1-karboksilne kiseline te povezani spojevi kao modulatori amid hidrolaze masnih kiselina (faah) za lijeäśenje tjeskobe, boli i drugih stanja |
| JP2008540370A (ja) | 2005-05-04 | 2008-11-20 | エフ.ホフマン−ラ ロシュ アーゲー | ヘテロ環式抗ウイルス化合物 |
| AU2011205048B2 (en) * | 2005-05-13 | 2013-05-02 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| NZ563909A (en) | 2005-05-13 | 2011-10-28 | Virochem Pharma Inc | Thiophene derivatives and their use for the treatment or prevention of flavivirus infections |
| DE602006003661D1 (de) | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
| BRPI0619730A2 (pt) * | 2005-12-12 | 2011-10-11 | Genelabs Tech Inc | compostos antivirais de n-(anel aromático de 5 membros)-amido |
| GB0526255D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
| WO2007071434A1 (en) * | 2005-12-22 | 2007-06-28 | Smithkline Beecham Corporation | Antiviral 2-carboxy-thiophene compounds |
| WO2008008912A1 (en) * | 2006-07-14 | 2008-01-17 | Genelabs Technologies, Inc. | Antiviral agents |
| WO2008017688A1 (en) * | 2006-08-11 | 2008-02-14 | Smithkline Beecham Corporation | 2-carboxy thiophene derivatives as anti-viral agents |
| EP2065369A4 (en) * | 2006-08-23 | 2011-12-28 | Astellas Pharma Inc | UREA CONNECTION OR SALT THEREOF |
| NZ575889A (en) | 2006-10-10 | 2011-09-30 | Medivir Ab | Hcv nucleoside inhibitor |
| WO2008043791A2 (en) * | 2006-10-13 | 2008-04-17 | Smithkline Beecham Corporation | Thiophene derivatives for treating hepatitis c |
| NZ576780A (en) * | 2006-11-15 | 2011-12-22 | Virochem Pharma Inc | Thiophene analogues for the treatment or prevention of flavivirus infections |
| US20090274655A1 (en) * | 2006-11-17 | 2009-11-05 | Richard Martin Grimes | 2-carboxy thiophene derivatives as anti viral agents |
| GB0707092D0 (en) * | 2007-04-12 | 2007-05-23 | Smithkline Beecham Corp | Compounds |
| CN101815533A (zh) | 2007-05-04 | 2010-08-25 | 弗特克斯药品有限公司 | 用于治疗hcv感染的组合治疗 |
| AU2008263166A1 (en) * | 2007-05-25 | 2008-12-18 | Janssen Pharmaceutica N.V. | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| GB0712393D0 (en) * | 2007-06-26 | 2007-08-01 | Smithkline Beecham Corp | Compounds |
| US8178699B2 (en) * | 2008-07-30 | 2012-05-15 | Pfizer Inc. | Modulators of CCR9 receptor and methods of use thereof |
| CA2734500A1 (en) * | 2008-08-27 | 2010-03-11 | Calcimedica Inc. | Compounds that modulate intracellular calcium |
| WO2010031832A2 (en) * | 2008-09-18 | 2010-03-25 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative |
| WO2010039801A2 (en) | 2008-10-02 | 2010-04-08 | The J. David Gladstone Institutes | Methods of treating hepatitis c virus infection |
| US8461159B2 (en) * | 2008-11-25 | 2013-06-11 | Jannsen Pharmaceutica BV | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| US8598356B2 (en) * | 2008-11-25 | 2013-12-03 | Janssen Pharmaceutica Nv | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| SG171890A1 (en) | 2008-12-03 | 2011-07-28 | Presidio Pharmaceuticals Inc | Inhibitors of hcv ns5a |
| BRPI0922366B8 (pt) | 2008-12-03 | 2021-05-25 | Presidio Pharmaceuticals Inc | composto, composição farmacêutica e uso de um composto |
| ES2567047T3 (es) | 2008-12-23 | 2016-04-19 | Abbvie Inc. | Derivados de pirimidina anti-virales |
| EP2367823A1 (en) | 2008-12-23 | 2011-09-28 | Abbott Laboratories | Anti-viral compounds |
| EP2403860B1 (en) * | 2009-03-04 | 2015-11-04 | IDENIX Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole as hcv polymerase inhibitors |
| US8975247B2 (en) | 2009-03-18 | 2015-03-10 | The Board Of Trustees Of The Leland Stanford Junion University | Methods and compositions of treating a flaviviridae family viral infection |
| EP2410843A4 (en) | 2009-03-27 | 2012-08-08 | Presidio Pharmaceuticals Inc | FUSIONED CORE INHIBITORS OF HEPATITIS C |
| JP5734956B2 (ja) * | 2009-04-15 | 2015-06-17 | アッヴィ・インコーポレイテッド | 抗ウィルス化合物 |
| WO2010141817A1 (en) | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
| WO2010141809A1 (en) | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase |
| AR077060A1 (es) * | 2009-06-11 | 2011-07-27 | Abbott Lab | Compuestos antivirales |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| EA020816B1 (ru) * | 2009-07-21 | 2015-01-30 | Джилид Сайэнс, Инк. | Ингибиторы вирусов flaviviridae |
| JP5774008B2 (ja) | 2009-09-09 | 2015-09-02 | ギリアード サイエンシーズ, インコーポレイテッド | Flaviviridaeウイルスの阻害剤 |
| MX2012005528A (es) | 2009-11-14 | 2012-06-12 | Hoffmann La Roche | Biomarcadores para pronosticar rapida respuesta a tratamiento hcv. |
| AU2010326225A1 (en) * | 2009-11-25 | 2012-06-07 | Vertex Pharmaceuticals Incorporated | 5-alkynyl-thiophene-2-carboxylic acid derivatives and their use for the treatment or prevention of flavivirus infections |
| KR20120085877A (ko) | 2009-12-02 | 2012-08-01 | 에프. 호프만-라 로슈 아게 | Hcv 치료에 대한 지속된 반응을 예측하기 위한 생체마커 |
| CA2784036A1 (en) | 2009-12-24 | 2011-06-30 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
| AU2011205744B2 (en) | 2010-01-15 | 2015-06-25 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| KR20120123678A (ko) | 2010-01-15 | 2012-11-09 | 길리애드 사이언시즈, 인코포레이티드 | 플라비비리다에 바이러스의 억제제 |
| EP2528605A1 (en) | 2010-01-29 | 2012-12-05 | Vertex Pharmaceuticals Incorporated | Therapies for treating hepatitis c virus infection |
| WO2011119858A1 (en) | 2010-03-24 | 2011-09-29 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
| WO2011119860A1 (en) | 2010-03-24 | 2011-09-29 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
| CA2794145A1 (en) | 2010-03-24 | 2011-09-29 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
| AU2011232348A1 (en) | 2010-03-24 | 2012-10-11 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of Flavivirus infections |
| UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
| EP2575866A4 (en) | 2010-05-24 | 2013-10-16 | Presidio Pharmaceuticals Inc | HCV NS5A INHIBITORS |
| NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
| EP2582717A2 (en) | 2010-06-15 | 2013-04-24 | Vertex Pharmaceuticals Incorporated | Hcv ns5b polymerase mutants |
| MX2012014918A (es) | 2010-06-28 | 2013-04-08 | Vertex Pharma | Compuestos y metodos para tratamiento o prevencion de infecciones por flavivirus. |
| EP2585448A1 (en) | 2010-06-28 | 2013-05-01 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
| WO2012006070A1 (en) | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
| BR112013001516A2 (pt) * | 2010-07-22 | 2016-06-07 | Novartis Ag | compostos de tiofeno 2,3,5-trissubstituídos e empregos destes |
| WO2012020036A1 (en) | 2010-08-13 | 2012-02-16 | F. Hoffmann-La Roche Ag | Hepatitis c virus inhibitors |
| AU2011292040A1 (en) | 2010-08-17 | 2013-03-07 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of Flaviviridae viral infections |
| BR112013009789A2 (pt) | 2010-10-26 | 2016-07-19 | Presidio Pharmaceuticals Inc | inibidores do vírus da hepatite c |
| TW201307334A (zh) | 2010-12-17 | 2013-02-16 | Cocrystal Discovery Inc | C型肝炎病毒聚合酶抑制劑 |
| WO2012116452A1 (en) * | 2011-03-03 | 2012-09-07 | Denovamed Inc. | Antimicrobial/adjuvant compounds and methods |
| US20140057953A1 (en) * | 2011-03-03 | 2014-02-27 | Rolf Hartmann | Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors |
| WO2012123298A1 (en) | 2011-03-11 | 2012-09-20 | F. Hoffmann-La Roche Ag | Antiviral compounds |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| WO2012175581A1 (en) | 2011-06-24 | 2012-12-27 | F. Hoffmann-La Roche Ag | Antiviral compounds |
| AU2012280959B2 (en) | 2011-07-13 | 2015-08-06 | Gilead Sciences, Inc. | Thiophen-2-carboxylic acid derivatives useful as inhibitors of Flaviviridae viruses |
| WO2013016499A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Methods for preparation of thiophene compounds |
| WO2013016501A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Formulations of thiophene compounds |
| BR112014008616A2 (pt) | 2011-10-10 | 2017-04-18 | Hoffmann La Roche | compostos antivirais |
| CN103059042B (zh) * | 2011-10-18 | 2015-10-07 | 银杏树药业(苏州)有限公司 | 噻吩类衍生物及其在药学中的用途 |
| AU2012347785B2 (en) | 2011-12-06 | 2017-03-16 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating viral diseases |
| ES2564906T3 (es) | 2011-12-16 | 2016-03-29 | F. Hoffmann-La Roche Ag | Inhibidores de NS5A del VHC |
| AU2012357986B2 (en) | 2011-12-20 | 2017-02-02 | Riboscience Llc | 4'-Azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| EP2794629B1 (en) | 2011-12-20 | 2017-05-24 | Riboscience LLC | 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication |
| US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
| KR20140130449A (ko) | 2012-02-24 | 2014-11-10 | 에프. 호프만-라 로슈 아게 | 항바이러스 화합물 |
| NZ630805A (en) | 2012-03-22 | 2016-01-29 | Alios Biopharma Inc | Pharmaceutical combinations comprising a thionucleotide analog |
| WO2014055142A1 (en) | 2012-06-20 | 2014-04-10 | Cocrystal Discovery, Inc. | Inhibitors of hepatitis c virus polymerase |
| US20140010783A1 (en) | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
| US8841340B2 (en) | 2012-08-17 | 2014-09-23 | Gilead Sciences, Inc. | Solid forms of an antiviral compound |
| US8927741B2 (en) | 2012-08-17 | 2015-01-06 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| US8759544B2 (en) | 2012-08-17 | 2014-06-24 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| EP2922596B1 (en) | 2012-08-31 | 2018-05-23 | Novadrug, LLC | Heterocyclyl carboxamides for treating viral diseases |
| CN105073726B (zh) | 2013-01-23 | 2017-05-31 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒三唑衍生物 |
| US20150065439A1 (en) | 2013-02-28 | 2015-03-05 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
| CN105008350B (zh) | 2013-03-05 | 2018-05-08 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒化合物 |
| US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
| RU2534613C2 (ru) | 2013-03-22 | 2014-11-27 | Александр Васильевич Иващенко | Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения |
| US20180200280A1 (en) | 2013-05-16 | 2018-07-19 | Riboscience Llc | 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
| MA38678A1 (fr) | 2013-05-16 | 2017-07-31 | Riboscience Llc | Dérivés nucléosidiques 4'-azido, 3'désoxy-3'-fluoro substitués |
| US9895442B2 (en) | 2013-05-16 | 2018-02-20 | Riboscience Llc | 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication |
| EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
| JP6523328B2 (ja) | 2014-04-17 | 2019-05-29 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | タンニン酸シタグリプチン複合体 |
| WO2016007540A2 (en) * | 2014-07-10 | 2016-01-14 | The J. David Gladstone Institutes | Compositions and methods for treating dengue virus infection |
| WO2016090313A1 (en) * | 2014-12-05 | 2016-06-09 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use |
| TWI731854B (zh) | 2015-03-23 | 2021-07-01 | 美商共結晶製藥公司 | C型肝炎病毒聚合酶之抑制劑 |
| CN111194217B (zh) | 2017-09-21 | 2024-01-12 | 里伯赛恩斯有限责任公司 | 作为hcv rna复制抑制剂的4’-氟-2’-甲基取代的核苷衍生物 |
| US11970474B2 (en) * | 2018-03-01 | 2024-04-30 | Thomas Helledays Stiftelse För Medicinsk Forskning | Substituted benzodiazoles and use thereof in therapy |
| KR20210018806A (ko) | 2018-05-09 | 2021-02-18 | 코크리스탈 파마, 아이엔씨. | Hcv의 치료를 위한 병용 요법 |
| CN108558822B (zh) * | 2018-06-01 | 2020-12-18 | 盐城锦明药业有限公司 | N-((5-溴噻吩-2-基)磺酰基)-2,4-二氯苯甲酰胺的合成方法 |
| US20230271932A1 (en) * | 2020-06-16 | 2023-08-31 | Dana-Farber Cancer Institute, Inc. | Small molecule covalent activators of ucp1 |
Family Cites Families (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3076817A (en) | 1963-02-05 | New j-amino-thiophene-z | ||
| DE1055077B (de) | 1956-02-08 | 1959-04-16 | Bayerische Schrauben Und Feder | Telephonkabelsteckverbinder |
| DE1055007B (de) | 1957-08-29 | 1959-04-16 | Dr Hans Fiesselmann | Verfahren zur Herstellung von 3-Aminothiophen-2-carbonsaeureestern und den entsprechenden freien Carbonsaeuren |
| US3470151A (en) * | 1966-05-17 | 1969-09-30 | Beecham Group Ltd | Furyl- and thienyl-penicillins and salts thereof |
| JPS4810463B1 (enExample) | 1967-07-07 | 1973-04-03 | ||
| US3823161A (en) | 1970-05-07 | 1974-07-09 | Exxon Research Engineering Co | Aminothiophene derivatives |
| US3852293A (en) | 1972-06-21 | 1974-12-03 | Uniroyal Inc | 4-phenyl-2-(3-pyridyl)-thiazole carboxamides |
| AU518216B2 (en) * | 1977-09-06 | 1981-09-17 | Hafslund Nycomed Pharma Aktiengesellschaft | Thienothiazine derivatives |
| DD146952A1 (de) | 1979-11-09 | 1981-03-11 | Karl Gewald | Verfahren zur herstellung von substituierten 3-amino-4-cyan-5-phenylthiophenen |
| JPS57116077A (en) | 1981-01-12 | 1982-07-19 | Kanebo Ltd | Thieno(3,2-b)pyridinecarboxylic acid derivative |
| US4666502A (en) | 1982-02-09 | 1987-05-19 | Sandoz Ltd. | Herbicidal N-thienyl-chloroacetamides |
| ATE26720T1 (de) | 1982-09-09 | 1987-05-15 | Hoffmann La Roche | Thieno(2,3-e)-1,2-thiazin-derivate. |
| GB8515207D0 (en) | 1985-06-15 | 1985-07-17 | Boots Co Plc | Therapeutic agents |
| JPS63126884A (ja) | 1986-11-17 | 1988-05-30 | Sankyo Co Ltd | オキサゾロチエノピリミジン誘導体 |
| GB8627698D0 (en) | 1986-11-20 | 1986-12-17 | Boots Co Plc | Therapeutic agents |
| DD263055A1 (de) | 1987-07-28 | 1988-12-21 | Univ Dresden Tech | Verfahren zur herstellung substituierter 3-amino-5-phenyl-thiophene |
| ATE127122T1 (de) | 1990-06-23 | 1995-09-15 | Basf Ag | Dicarbonsäureimide als herbizide. |
| DE4023048A1 (de) | 1990-07-20 | 1992-01-23 | Basf Ag | Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
| JP2574085B2 (ja) | 1991-10-28 | 1997-01-22 | 株式会社トクヤマ | 3−アミノ−2−チオフェンカルボン酸誘導体の製造方法 |
| FR2689129B1 (fr) | 1992-03-27 | 1995-05-12 | Atochem Elf Sa | Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation. |
| JPH0625221A (ja) | 1992-07-10 | 1994-02-01 | Tokuyama Soda Co Ltd | 3−アミノ−2−チオフェンカルボン酸誘導体の製造方法 |
| DE4244069A1 (de) | 1992-12-24 | 1994-06-30 | Hoechst Ag | Cephalosporinsalze und Verfahren zu deren Herstellung |
| JPH0748360A (ja) | 1993-05-31 | 1995-02-21 | Yoshitomi Pharmaceut Ind Ltd | ビフェニルテトラゾール誘導体 |
| JPH0718360A (ja) | 1993-07-07 | 1995-01-20 | Sumitomo Light Metal Ind Ltd | 耐摩耗性に優れたTi−Al系金属間化合物部材及びその製造方法 |
| EP0658559A1 (de) | 1993-12-14 | 1995-06-21 | Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. | Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren |
| AU6788996A (en) | 1995-08-02 | 1997-02-26 | J. Uriach & Cia S.A. | New carboxamides with antifungal activity |
| EP0783501B9 (en) | 1995-08-02 | 2001-07-25 | J. URIACH & CIA. S.A. | pyrimidone derivatives with antifungal activity |
| WO1998008839A1 (en) | 1996-08-26 | 1998-03-05 | Eli Lilly And Company | Combinatorial process for preparing substituted thiophene libraries |
| JP4000608B2 (ja) | 1996-11-07 | 2007-10-31 | トヨタ自動車株式会社 | 水素製造充填装置および電気自動車 |
| TW523506B (en) * | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
| WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| AP9901643A0 (en) | 1997-04-28 | 1999-10-02 | Texas Biotechnology Corp | Sulfonamides for treatment of endothelin-mediated disorders. |
| WO1998052559A1 (en) * | 1997-05-23 | 1998-11-26 | Bayer Corporation | Raf kinase inhibitors |
| US6344476B1 (en) | 1997-05-23 | 2002-02-05 | Bayer Corporation | Inhibition of p38 kinase activity by aryl ureas |
| JP4344960B2 (ja) | 1997-05-23 | 2009-10-14 | バイエル、コーポレイション | アリール尿素によるp38キナーゼ活性の阻害 |
| US6187799B1 (en) * | 1997-05-23 | 2001-02-13 | Onyx Pharmaceuticals | Inhibition of raf kinase activity using aryl ureas |
| NZ503484A (en) | 1997-09-02 | 2001-10-26 | Welfide Corp | Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives |
| US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| US7329670B1 (en) | 1997-12-22 | 2008-02-12 | Bayer Pharmaceuticals Corporation | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| AU2003204708B2 (en) | 1997-12-22 | 2006-05-25 | Bayer Healthcare Llc | Inhibition of Raf Kinase using Substituted Heterocyclic Ureas |
| US20070244120A1 (en) | 2000-08-18 | 2007-10-18 | Jacques Dumas | Inhibition of raf kinase using substituted heterocyclic ureas |
| US6291514B1 (en) | 1998-02-09 | 2001-09-18 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors |
| US6262044B1 (en) | 1998-03-12 | 2001-07-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPASES) |
| US20050119332A1 (en) | 1998-03-12 | 2005-06-02 | Lone Jeppesen | Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| US6214879B1 (en) | 1998-03-24 | 2001-04-10 | Virginia Commonwealth University | Allosteric inhibitors of pyruvate kinase |
| US6147085A (en) * | 1999-04-01 | 2000-11-14 | Neurogen Corporation | Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives |
| US6689754B1 (en) | 1998-04-10 | 2004-02-10 | G. D. Searle & Co. | Heterocyclic glycyl β-alanine derivatives |
| DK0957099T3 (da) | 1998-04-15 | 2003-03-17 | Pfizer Prod Inc | Heterocykliske carboxamider |
| EP0960882A1 (en) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| US6858223B2 (en) * | 1998-06-23 | 2005-02-22 | Altana Pharma Ag | Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) |
| ATE253061T1 (de) * | 1998-06-29 | 2003-11-15 | Iaf Biochem Int | Zur behandlung von krebs nützliche thiophen- und furan-2,5-dicarboxamide |
| HRP20010206A2 (en) * | 1998-08-20 | 2004-02-29 | Agouron Pharma | NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| US7101878B1 (en) | 1998-08-20 | 2006-09-05 | Agouron Pharmaceuticals, Inc. | Non-peptide GNRH agents, methods and intermediates for their preparation |
| DE19903398A1 (de) | 1999-01-29 | 2000-08-10 | Hassan Jomaa | Verwendung von Thiadiazolderivaten zur prophylaktischen und therapeutischen Behandlung von Infektionen |
| JP2003529536A (ja) | 1999-02-09 | 2003-10-07 | 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド | C1s介在疾患および状態の処置法、およびそれのための化合物および組成物 |
| DE60023853T2 (de) | 1999-03-12 | 2006-05-24 | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | Aromatische heterozyklische verbindungen als antientzündungwirkstoffe |
| HUP0202248A3 (en) * | 1999-03-12 | 2006-06-28 | Boehringer Ingelheim Pharma | Compounds useful as anti-inflammatory agents |
| JP2001010957A (ja) | 1999-04-28 | 2001-01-16 | Sankyo Co Ltd | 肝障害の予防または抑制剤 |
| DE19920247A1 (de) | 1999-05-03 | 2000-11-16 | Hassan Jomaa | Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung |
| HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
| US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| GB9929552D0 (en) | 1999-12-14 | 2000-02-09 | Proteus Molecular Design | Compounds |
| CA2385972A1 (en) | 1999-10-01 | 2001-04-12 | Haruhisa Ogita | Novel diarylamide derivatives and use thereof as medicines |
| WO2001040206A1 (en) * | 1999-11-29 | 2001-06-07 | Novartis Ag | Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| DE10002424A1 (de) * | 2000-01-20 | 2001-07-26 | Siemens Ag | Di(het)arylaminothiophen-Derivate |
| GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| MY138097A (en) | 2000-03-22 | 2009-04-30 | Du Pont | Insecticidal anthranilamides |
| WO2001083460A1 (en) | 2000-04-28 | 2001-11-08 | Tanabe Seiyaku Co., Ltd. | Cyclic compounds |
| JP2001354658A (ja) | 2000-06-15 | 2001-12-25 | Taisho Pharmaceut Co Ltd | ヒドロキシホルムアミジン化合物及びその塩並びにそれらを含む医薬 |
| US6414013B1 (en) * | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| AU2002213048A1 (en) | 2000-10-05 | 2002-04-15 | Smith Kline Beecham Corporation | Phosphate transport inhibitors |
| IL155623A0 (en) * | 2000-11-08 | 2003-11-23 | Syngenta Participations Ag | Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses |
| US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| US6892279B2 (en) * | 2000-11-30 | 2005-05-10 | Mosaid Technologies Incorporated | Method and apparatus for accelerating retrieval of data from a memory system with cache by reducing latency |
| DE10061876A1 (de) | 2000-12-12 | 2002-06-20 | Aventis Pharma Gmbh | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| WO2002064598A1 (en) | 2001-02-14 | 2002-08-22 | Warner-Lambert Company Llc | Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| EP1364212B1 (en) | 2001-03-02 | 2011-02-02 | GPC Biotech AG | Three hybrid assay system |
| US20040102324A1 (en) | 2002-02-28 | 2004-05-27 | Annis Gary David | Heterocyclic diamide invertebrate pest control agents |
| CN1774635A (zh) | 2001-03-13 | 2006-05-17 | 金斯顿皇后大学 | 抗癫痫发生剂 |
| US6734207B2 (en) * | 2001-04-20 | 2004-05-11 | Parker Hughes Institute | Cytotoxic compounds |
| US6713638B2 (en) * | 2001-05-18 | 2004-03-30 | Joel M. Linden | 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors |
| CA2449999C (en) | 2001-06-11 | 2012-07-31 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| EA007484B1 (ru) * | 2001-06-11 | 2006-10-27 | Вирокем Фарма Инк. | Соединения и способы лечения или предупреждения инфекций flavivirus |
| SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| SE0102617D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| JP2003073357A (ja) | 2001-09-03 | 2003-03-12 | Mitsubishi Pharma Corp | アミド化合物を含有するRhoキナーゼ阻害剤 |
| US6924276B2 (en) | 2001-09-10 | 2005-08-02 | Warner-Lambert Company | Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| US7166639B2 (en) * | 2001-10-04 | 2007-01-23 | Smithkline Beecham Corporation | NF-κB inhibitors |
| US7285557B2 (en) | 2001-10-15 | 2007-10-23 | Smithkline Beecham P.L.C. | Pyrimidinones as melanin concentrating hormone receptor 1 |
| US7220777B2 (en) | 2001-10-15 | 2007-05-22 | Smithkline Beecham P.L.C. | Lactam derivatives as antagonists for human 11cby receptors |
| TWI281916B (en) * | 2001-10-25 | 2007-06-01 | Lilly Co Eli | Antitumor compounds and methods |
| WO2003055479A1 (en) * | 2001-12-21 | 2003-07-10 | Consejo Superior De Investigaciones Cientificas | Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3 |
| US6835745B2 (en) * | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
| US20040023961A1 (en) | 2002-02-11 | 2004-02-05 | Bayer Corporation | Aryl ureas with raf kinase and angiogenisis inhibiting activity |
| US20030220336A1 (en) | 2002-04-05 | 2003-11-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method of treating mucus hypersecretion |
| PL372246A1 (en) * | 2002-05-28 | 2005-07-11 | 3-Dimensional Pharmaceuticals, Inc. | Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| CN1155679C (zh) | 2002-09-20 | 2004-06-30 | 华南理工大学 | 含低聚噻吩骨格的液晶化合物及其制备方法 |
| US7179836B2 (en) * | 2002-09-20 | 2007-02-20 | Smithkline Beecham Corporation | Chemical compounds |
| WO2004037789A2 (en) | 2002-10-24 | 2004-05-06 | Merck Patent Gmbh | Methylene urea derivatives as raf-kinase inhibitors |
| US20040162285A1 (en) | 2002-11-01 | 2004-08-19 | Pratt John K. | Anti-infective agents |
| US20050075331A1 (en) | 2003-10-06 | 2005-04-07 | Pratt John K. | Anti-infective agents |
| US20040097492A1 (en) | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| KR20050065670A (ko) | 2002-11-01 | 2005-06-29 | 아보트 러보러터리즈 | 항감염제 |
| US7902203B2 (en) | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
| PT1569929E (pt) | 2002-12-10 | 2010-06-18 | Virochem Pharma Inc | Compostos e métodos para o tratamento ou prevenção de infecções por flavivírus |
| US20040192707A1 (en) | 2002-12-10 | 2004-09-30 | Laval Chan Chun Kong | Compounds and methods for the treatment or prevention of Flavivirus infections |
| US7098241B2 (en) * | 2002-12-16 | 2006-08-29 | Hoffmann-La Roche Inc. | Thiophene hydroxamic acid derivatives |
| DE10359791A1 (de) | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Substituierte Thiophene |
| WO2005095386A1 (en) | 2004-03-30 | 2005-10-13 | Chiron Corporation | Substituted thiophene derivatives as anti-cancer agents |
| DE102005028077A1 (de) | 2004-12-22 | 2006-07-13 | Aicuris Gmbh & Co. Kg | Alkinyl-substituierte Thiophene |
| NZ563909A (en) * | 2005-05-13 | 2011-10-28 | Virochem Pharma Inc | Thiophene derivatives and their use for the treatment or prevention of flavivirus infections |
-
2002
- 2002-06-11 EA EA200400022A patent/EA007484B1/ru not_active IP Right Cessation
- 2002-06-11 JP JP2003503618A patent/JP4544857B2/ja not_active Expired - Fee Related
- 2002-06-11 SI SI200230851T patent/SI1401825T1/sl unknown
- 2002-06-11 CN CN200910139375A patent/CN101624391A/zh active Pending
- 2002-06-11 CN CNB028157680A patent/CN100509797C/zh not_active Expired - Fee Related
- 2002-06-11 AP APAP/P/2003/002932A patent/AP1753A/en active
- 2002-06-11 PT PT02742563T patent/PT1401825E/pt unknown
- 2002-06-11 PL PL367080A patent/PL208713B1/pl not_active IP Right Cessation
- 2002-06-11 MX MXPA03011452A patent/MXPA03011452A/es active IP Right Grant
- 2002-06-11 BR BR0210357-5A patent/BR0210357A/pt not_active IP Right Cessation
- 2002-06-11 EP EP10185737A patent/EP2363396A1/en not_active Withdrawn
- 2002-06-11 CZ CZ20033368A patent/CZ20033368A3/cs unknown
- 2002-06-11 KR KR1020037016240A patent/KR100900304B1/ko not_active Expired - Fee Related
- 2002-06-11 DE DE60233227T patent/DE60233227D1/de not_active Expired - Lifetime
- 2002-06-11 EP EP09167203A patent/EP2206709A3/en not_active Withdrawn
- 2002-06-11 DK DK02742563T patent/DK1401825T3/da active
- 2002-06-11 AU AU2002344854A patent/AU2002344854B2/en not_active Ceased
- 2002-06-11 SK SK1520-2003A patent/SK288015B6/sk not_active IP Right Cessation
- 2002-06-11 CA CA2450007A patent/CA2450007C/en not_active Expired - Fee Related
- 2002-06-11 AT AT02742563T patent/ATE438637T1/de active
- 2002-06-11 PL PL395097A patent/PL395097A1/pl unknown
- 2002-06-11 WO PCT/CA2002/000876 patent/WO2002100851A2/en not_active Ceased
- 2002-06-11 US US10/166,031 patent/US6881741B2/en not_active Expired - Fee Related
- 2002-06-11 ES ES02742563T patent/ES2330313T3/es not_active Expired - Lifetime
- 2002-06-11 EP EP02742563A patent/EP1401825B1/en not_active Expired - Lifetime
- 2002-06-11 OA OA1200300320A patent/OA12622A/en unknown
-
2003
- 2003-12-10 NO NO20035485A patent/NO331721B1/no not_active IP Right Cessation
- 2003-12-10 ZA ZA200309590A patent/ZA200309590B/en unknown
-
2005
- 2005-01-26 US US11/042,442 patent/US7985769B2/en not_active Expired - Fee Related
-
2009
- 2009-02-05 AU AU2009200430A patent/AU2009200430B2/en not_active Ceased
- 2009-10-22 CY CY20091101100T patent/CY1109497T1/el unknown
-
2010
- 2010-04-28 JP JP2010103706A patent/JP5412370B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL208713B1 (pl) | Związek stanowiący pochodną tiofenu, kompozycja farmaceutyczna zawierająca taki związek i jego zastosowanie | |
| AU2002344854A1 (en) | Thiophene derivatives as antiviral agents for flavivirus infection | |
| EP1322642B1 (en) | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of Protein Jun-kinases | |
| CA2508990C (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
| ES2415742T3 (es) | Compuestos y procedimientos para el tratamiento o prevención de infecciones por flavivirus | |
| ES2345438T3 (es) | Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus. | |
| US20080255222A1 (en) | Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases | |
| US8329924B2 (en) | Compounds and methods for the treatment or prevention of Flavivirus infections | |
| HK1146043A (en) | Thiophene derivatives as antiviral agents for flavivirus infection | |
| HK1161595A (en) | Thiophene derivatives as antiviral agents for flavivirus infection | |
| HK1139944A (en) | Thiophene derivatives as antiviral agents for flavivirus infection | |
| AU2012202716A1 (en) | Thiophene derivatives as antiviral agents for flavivirus infection | |
| HK1177453A (en) | Compounds and methods for the treatment or prevention of flavivirus infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification | ||
| RECP | Rectifications of patent specification | ||
| DISD | Decisions on discontinuance of the proceedings of a derived patent or utility model |
Ref document number: 395097 |
|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20140611 |